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Human noroviruses (HNoVs) are considered the leading cause of acute non-bacterial 
gastroenteritis worldwide. Effective chemical disinfectants to inactivate HNoVs are needed. 
Since HNoVs cannot be cultivated in the lab, cultivable surrogates, feline calicivirus (FCV-F9) 
and murine norovirus (MNV-1), are used to determine inactivation using infectivity plaque 
assays. This study aimed to:  1) determine the ability of benzalkonium chloride (BAC) and 
potassium peroxymonosulfate (KPMS) to inactivate FCV-F9 and MNV-1 in vitro using 
suspension and carrier tests under clean and simulated dirty (5% fetal bovine serum) conditions 
over 1 h at room temperature; 2) determine inactivation of FCV-F9 and MNV-1 in suspension 
and carrier tests over 1 h at room temperature by sodium metasilicate (SMS). In suspension tests, 
BAC caused 1.94 and 2.59 log reductions of low and high FCV-F9 titers after 1 h, respectively. 
MNV-1 at low and high titers was reduced by > 3 and 1.47 logs with BAC after 1 h, respectively. 
KPMS at 5 and 10 mg/mL reduced low titers of both viruses to non-detectable levels within 30 s. 
High FCV-F9 titers were non-detectable after 2 min with 5 mg/mL and within 30 s with 10 
mg/mL of KPMS. KPMS at 5 mg/mL had little effect against high titers of MNV-1, but caused a 
4.61 log reduction after 5 min with 10 mg/mL of KPMS. Using clean carrier tests, KPMS at 5 
and 10 mg/mL reduced both tested viruses at low titers after 30 s and only high FCV-F9 titers 
after 10 min to undetectable levels. MNV-1 at high titers were reduced to non-detectable levels 
after 15 min with 10 mg/mL KPMS. BAC reduced low titers of both viruses to undetectable 
levels after 1 h using carrier tests with no significant reduction of high titers even after 2 h. The 
antiviral effect of both chemicals decreased under simulated dirty conditions. Both viruses were 
reduced within 15 s by 5% and 10% SMS using suspension tests. FCV-F9 and MNV-1 at high 
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titers were reduced to undetectable levels after 2 min and 15 s, respectively with 2% SMS. 
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 LITERATURE REVIEW 
 
Introduction 
 Foodborne illnesses are regarded as leading public health concerns worldwide as causes 
of morbidity and mortality. It is estimated that foodborne diseases cause approximately 9.4 
million illnesses, 55961 hospitalizations, and 1351 deaths in the United States each year 
associated with 31 known pathogens (Scallan et al., 2011). The causative agents of foodborne 
illness include viruses, bacteria, parasites, toxins, metals, and prions (Mead et al., 1999). Among 
them, viruses are currently considered the leading cause of foodborne illnesses, responsible for 
59% (5.5 million) of foodborne disease cases (Scallan et al., 2011).  
Enteric viruses that can be transmitted by foodborne or waterborne routes include human 
caliciviruses (noroviruses, sapoviruses, vesiviruses and lagoviruses), hepatitis A and E virus, 
human enteroviruses (poliovirus, coxsackie A and B, echovirus, enterovirus serotypes 68-71), 
astroviruses, other small round viruses, parvoviruses, and rotavirus (Sair et al., 2002). From an 
epidemiological perspective, the agents that are responsible for the most common cause of acute 
viral gastroenteritis around the world are human noroviruses. Current estimates are that human 
noroviruses are responsible for approximately 3.2 million (58%) illnesses, 14,550 (26%) 
hospitalizations and 287 (11%) deaths annually in the U.S. alone (Scallan et al., 2011). However, 
these figures can be considered as an underestimate due to the disease being under-reported and 
cases frequently undetected or outbreaks being uninvestigated. Therefore, it is imperative to 
develop effective inactivation strategies to control human norovirus spread and prevent their 
outbreaks in food processing and nosocomial environments.  
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Human Norovirus and its Surrogates 
Human norovirus was first discovered by Albert Kapikian in 1972 using immune electron 
microscopy (IEM) of stool samples collected from a 1968 outbreak of gastroenteritis in Norwalk, 
Ohio, USA (Kapikian et al., 1972). Since then, the so-called “Norwalk virus” began to be 
significantly recognized. Norovirus, the prototype member of small round structured viruses 
(SRSVs), belongs to the family Caliciviridae based on the genetic sequencing work (Jiang et al., 
1993; Xi et al., 1990). Currently, this family is comprised of four genera: noroviruses 
(represented by Norwalk-like viruses, having Norwalk virus prototype strain), sapoviruses 
(represented by Sapporo-like viruses, having Sapporo virus prototype strain), vesiviruses 
(represented by vesicular exanthema of swine virus and feline calicivirus) and lagoviruses 
(represented by rabbit hemorrhagic disease virus and European brown hare syndrome virus), the 
former two genera being significant to human epidemic gastroenteritis (D’Souza et al., 2007; 
Sair et al., 2002).  
The genus norovirus is comprised of a genetically diverse group of non-enveloped, 
single-stranded, positive sense RNA viruses. These viruses are icosahedral in shape with a 
diameter of 27 to 35 nm; and buoyant density of 1.33-1.41 g/cm3 in CsCl (Kapikian et al., 1972). 
The norovirus capsid protein consists of 180 capsid protein molecules possessing a molecular 
weight ranging from 59,000 to 65,000 Da (Jiang et al., 1993; Kapikian et al., 1996). The 
norovirus genome consists of three open reading frames (ORF) to encode structural and non-
structural proteins. ORF1 possesses the longest nucleotides and encodes the non-structural 
proteins (RNA dependent RNA polymerase); ORF2 encodes the viral capsid protein; and ORF3 
encodes a small polypeptide conjectured to package the genome into virions (Donaldson et al., 
2008; Jiang et al., 1993).  
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Based on the sequencing analysis of the RNA-dependent RNA polymerase region and 
capsid protein region, noroviruses are classified into five genogroups. Genogroups (G) I, GII and 
GIV are associated with human infections and responsible for foodborne illness outbreaks; they 
are represented by the prototype Norwalk virus, prototype Snow Mountain agent and prototype 
Ft. Lauderdale virus, respectively. The other genogroups, GIII and GV are associated with animal 
infections, represented by prototype, bovine enteric calicivirus and prototype murine norovirus, 
respectively (D’Souza et al., 2007). Among human infecting genogroups, GII is predominant, 
responsible for the most human norovirus outbreaks. As reported previously, approximately 73% 
of human norovirus illnesses are caused by GII viruses (Zheng et al., 2006). The emerging of 
virulent strains including GII.4 can cause deaths in the elderly and immune-compromised 
(Siebenga et al., 2010). Norovirus genogroups can be further subdivided into genotypes, also known 
as genoclusters. Currently, GI is comprised of eight genotypes and GII has at least seventeen 
genotypes (Zheng et al., 2006).   
Human noroviruses, in a similar manner to other enteric viruses, can be transmitted by the 
fecal-oral route or by direct contact with an infected person as well as by consuming 
contaminated food or water or touching contaminated surfaces (Kukkula et al., 1999; Weinstein 
et al., 2008). Aerosolized vomitus is another transmission mode for human noroviruses 
(Patterson et al., 1997). The difficulty in controlling the spread of human noroviruses is due to 
their high primary and secondary attack rate, environmental stability and low infectious dose 
(Caul, 1994; D’Souza et al., 2006; Liu et al., 2009). Outbreaks associated with human 
noroviruses have occurred in a variety of closed settings, including healthcare facilities, 
restaurants, cruise ships, schools, hotels, and other institutional settings (CDC, 2011), as 
evidenced by the environmental persistence of human noroviruses. Further, the survival of 
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human noroviruses in human gastrointestinal tract indicates their persistence in the presence of 
degrading enzymes and extreme pH environments (Sair et al., 2002). Previous studies have 
shown that human noroviruses can be detected on food-contact surfaces for up to 7 days at room 
temperature; can persist at temperatures ranging from freezing to 60oC (30 min); at pH 2.7 for 3 
h at room temperature in stool; with treatment of 20% ether for 18 h at 4oC; and resistant to low 
concentrations of chlorine (3.75-6.25 mg/L) (D'Souza et al., 2006; D’Souza et al., 2007; Dolin et 
al., 1972; Patel et al., 2009; Teunis et al., 2008). The infectious dose of human noroviruses is 
quite low; only 10 infectious units can cause disease. The incubation period of human norovirus 
infection is typically 12-48 h and characterized by mild to severe gastroenteritis with symptoms 
include vomiting, nausea, diarrhea, and abdominal pain. The duration of the infection may last 
12-72 h; however, fecal viral shedding can be extended for several more days (Grohmann et al., 
1981; Cliver et al., 2002; D’Souza et al., 2007). Although, HNoV infection itself is self-limiting 
in healthy individuals, they can be life-threatening to the elderly and immune-compromised 
(Donaldson et al., 2010; Siebenga et al., 2009).  
To date, the major hurdle for gaining a better knowledge of human noroviruses lies in the 
fact that human noroviruses cannot be cultivated in cell culture. Therefore, cultivable surrogates 
are needed to study the basic pathology of human noroviruses, explore the environmental 
stability of these viruses and determine the efficacy of various control strategies. Several 
cultivable enteric caliciviruses within the Caliciviridae family have been utilized as human 
norovirus surrogates, including feline calicivirus (FCV-F9), murine norovirus (MNV-1), canine 
calicivirus (a vesivirus) (Mochizuki et al., 1993), Tulane virus (Farkas et al., 2008) and porcine 
enteric calicivirus (a sapovirus) (Guo et al., 1999). Currently, the most widely used surrogates 
are FCV-F9 and MNV-1, which are genetically similar to norovirus because they all belong to 
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the Caliciviridae family. FCV-F9 is positioned in the Vesivirus genus, causing acute oral and 
upper respiratory tract disease in feline populations, typically cats (Green et al., 2000; Radford et 
al., 2007). This virus has been extensively utilized as a surrogate for human norovirus as a model 
of evaluating viral persistence and reduction due to its ease of culture and quantification. 
However, unlike human norovirus, FCV-F9 is transmitted by the respiratory instead of the fecal-
oral route (Green et al., 2001). Further, this virus is more vulnerable to environmental stresses, 
being sensitive to low pH and elevated temperatures as well as chemical treatments (D'Souza and 
Su, 2010; Doultree et al., 1999; Slomka and Appleton, 1998). MNV-1, a recently cultivable 
surrogate for human norovirus, belongs to the Norovirus genus, which indicates more 
morphological and genetic similarity to human noroviruses; this virus is currently the only 
norovirus known in literature that is amenable to cell culture (Wobus et al., 2006). MNV-1 can 
infect and replicate in mice. Like human norovirus, this virus is transmitted via the fecal-oral 
route. Further, MNV-1 shares many biochemical and genetic characteristics with human strains, 
including size, shape and buoyant density (Wobus et al., 2006). With such similarities, MNV-1 
shows considerable promise as a surrogate for human noroviruses. However, there are 
differences. MNV-1 binds to sialic acid on the host cell surface as a receptor, while human 
norovirus recognizes the histoblood group antigens (HBGAs) (Taube et al., 2009); and the two 
viruses have different clinical manifestations for MNV-1 does not cause diarrhea or vomiting 
(Karst et al., 2003). Thus, an effective animal model is still being investigated. Recently, Tulane 
Virus has been cultivated in the laboratory and is considered an alternate surrogate to MNV-1 by 
some investigators (Li et al., 2012; Tan and Jiang, 2010). This enteric virus was isolated from 
stool samples of captive juvenile rhesus macaques, which can replicate in vitro in monkey cell 
lines (Farkas et al., 2008). Tulane virus has a diameter of 36 nm and a buoyant density of 1.37 
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g/mL; and most importantly, this virus recognizes human HBGAs as a receptor (Farkas et al., 
2010). However, Tulane virus belongs to a new calicivirus genus separate from 
the Norovirus genus and the pathogenicity of Tulane virus in rhesus macaques remains unknown 
(Farkas et al., 2008). Further, Hirneisen and Kniel compared the behavior of MNV-1 and Tulane 
virus and concluded that MNV-1 is a better surrogate for HNoV, as MNV-1 is more pH (2.0 to 
10.0) stable, more resistant to chlorine treatment at 2 ppm and more persistent in tap water at 4 
oC (Hirneisen and Kniel, 2013). Overall, the infectivity studies of surrogates can be used to gain 
a better understanding of human noroviruses; however, they cannot always model human strains. 
Hence, it is necessary to use caution when interpreting the results of surrogates. Feeding and 
challenge studies are deemed more suitable by some investigators.  
Chemical Inactivation of Human Norovirus surrogates 
To control the spread of human noroviruses and their emerging virulent forms, control 
strategies have been evaluated including heat inactivation, non-thermal methods, chemical and 
natural bioactives as alternates. Since human noroviruses can be transmitted via the fecal-oral 
route, human excretions including stool and vomit can be the main source of human norovirus 
environmental transmission. The titer of viral particle shed in the feces can be as high as 108 /g 
(Atmar et al., 2008). Therefore, it is imperative to implement control measures to interrupt the 
transmission of human noroviruses. The use of chemical disinfectants can be considered as an 
effective intervention strategy to prevent transmission of human noroviruses from contaminated 






Chlorine is an important chemical applied as a disinfectant to kill microorganisms in 
drinking water and swimming pools. Chlorine is the active ingredient of store-bought household 
bleach, which normally contains 5.7% available chlorine. The dosage typically used is 4 ppm for 
disinfecting water.  
The antiviral activity of free chlorine is proposed to occur by damaging the capsid as well 
as RNA (McDonnell and Russell, 1999). Li and others (2002) reported that chlorine at 10 or 20 
mg/L concentration could completely inactivate hepatitis A virus (HAV) after 30 min of 
exposure in a cell culture model. Using an enzyme-linked immunosorbent assay, the 
disappearance of antigenicity was observed after chlorine treatment/inactivation, which indicates 
that chlorine may target nucleic acids rather than capsid proteins. It was reported that the 
inactivation of HAV was due to the damage of the 5’ nontranslated regions (5’NTR), as 
evaluated by long-overlap RT-PCR (Li et al., 2002). Furthermore, Baert and others (2009) 
suggested that FCV, MS2 and HAV react similarly to chlorine because a similar decline was 
observed among FCV, MS2 and HAV (Baert et al., 2009). Allwood and others (2004) observed 
2.9 log reductions of both FCV and MS2 on leafy vegetables treated with 200 ppm chlorine after 
2 min of exposure (Allwood et al., 2004). Similarly, Casteel and others (2008) found that 
produce treated with 20 ppm chlorine for 10 min enabled a reduction of at least 1.7 log PFU/mL 
HAV and MS2 (Casteel et al., 2008).  
Chlorine was found to be effective against viruses based on the dose, contact time, and 
the type of viruses (Table 1.1). FCV was reduced by 2.9 log10 PFU/mL on lettuce after a 2 min 
treatment with 15 ppm chlorine, while MNV-1 was reduced by 1.4 log10 PFU/mL under the same 
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experimental conditions (Fraisse et al., 2011). Chlorine at 200 ppm reduced FCV-F9 at low titers 
(~5 log PFU/mL) on produce to undetectable levels after a short contact time of 15 s or 30 s, but 
only ≤1.4 log reduction of high titers (~7 log PFU/mL) (Su and D’Souza, 2011). MNV-1 reached 
lower reductions compared to FCV-F9 at both low and high titers under the same treatment and 
contact time with a 2~3 log-PFU reduction and <1.3 log-PFU reduction, respectively (Su and 
D’Souza, 2011).  Using a surface test, 5000 ppm of chlorine was found to almost completely 
inactivate FCV-F9 at both low titers (~5 log PFU/mL) and high titers (~7 log PFU/mL) after 30 s 
or 1 min contact time, respectively at room temperature (D’Souza and Su, 2010). Duizer and 
others (2004) suggested that chlorine at concentration of ≥3000 ppm could completely inactivate 
FCV-F9 after a 10 min exposure at room temperature (Duizer et al., 2004). Kitajima and others 
(2010) found that MNV-1 was inactivated by more than 4 logs after 120 min and 0.5 min contact 
time with initial free chlorine concentration of 0.1 and 0.5 mg/L, respectively (Kitajima et al., 
2010). The findings were similar with Belliot and others (2008), with inactivation of MNV-1 by 
>4 log after treatment with 0.26% chlorine after a 0.5 min contact time (Belliot et al., 2008). 
Using a suspension test, 0.3 ppm of free chlorine was found to reduce partially purified FCV-F9 
by >4.6 logs after a 5 min exposure (Urakami et al., 2007). However, Doultree and others (1999) 
observed a 5 log reduction in the infectivity of FCV-F9 after 1 min of exposure to a 
concentration of 5000 ppm free chlorine (Doultree et al., 1999). It is generally recognized that 
relatively higher concentrations of chlorine are needed to inactivate human norovirus surrogates 
on the surfaces. For example, Whitehead and McCue (2010) found that FCV-F9 with 100 ppm 
chlorine for 1 min resulted in <2.3 log reduction, but was reduced by >3 log with 1,000 ppm 
chlorine after the same exposure time (Whitehead and McCue, 2010). The results were similar to 
the reports by Jimenez and Chiang (2006). They observed a 3.2 log reduction treated by 100 ppm 
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chlorine and a 6.6 log reduction by 1,000 ppm chlorine after 10 min (Jimenez and Chiang, 2006). 
Gulati and others (2001) reported that, after a range of 1-10 min of exposure to different 
concentrations of chlorine, a <1 log reduction was observed by <800 ppm chlorine, while a 3.4 
log reduction with 5000 ppm chlorine was observed (Gulati et al., 2001). Similarly, Doultree and 
others (1999) found that <500 ppm and 5000 ppm of chlorine resulted in a <3 log and 5 log 
reduction, respectively after 1 min of contact time (Doultree et al., 1999). Fewer studies have 
been conducted with MNV-1. Girard and others (2010) observed that MNV-1 was completely 
inactivated by 3000 ppm free chlorine after both 5 min and 10 min exposure, as determined by 
infectivity assay, but with a 4 log reduction using real time RT-PCR (Girard et al., 2010).  
It is believed that the effect of chlorine on inactivating human norovirus surrogates is 
readily decreased by organic matter. For instance, Poschetto and others (2007) observed that 
FCV-F9 was reduced by >5 log with 4500-5000 ppm of free chlorine after 15 min contact time 
without feces, while with feces, a 4 log reduction was observed with 5500 ppm after the same 
exposure time (Poschetto et al., 2007).  
Although chlorine is effective against viruses, it may create harmful disinfection by-
products including trihalomethanes, which is dangerous to life and health, and produces 
unfavorable sensory effects. Chlorine can also bleach food and carcinogenic byproducts can be 
formed by the interaction of chlorine with organic matter (Dunnick and Melnick, 1993). Hence, 
alternate disinfectant methods are being sought. 
Alcohols:  
 Ethanol is a commonly employed sanitizer and disinfectant used in the general 
concentration range of 70%-75%. The mechanism of its antiviral activity is proposed to occur by 
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denaturing capsid proteins and dissolving the lipids of the enveloped viruses (McDonnell and 
Russell, 1999). Ethanol at 70% concentration has been evaluated most frequently by 
investigators for its efficacy against human norovirus surrogates. However, no conclusive 
suggestions/recommendations have been reached, as there are variable results against non-
enveloped viruses (Table 1.2). A few studies have reported that ethanol has a strong effect 
against FCV-F9 and MNV-1. For example, Di Martino and others (2010) found that 70% ethanol 
was able to inactive FCV-F9 by >4 log PFU/mL after a 10 min exposure, as evaluated by nested 
RT-PCR (Di Martino et al., 2010). Malik and others (2006), using tissue culture infectious dose 
50 (TCID50), showed that 70% and 90% ethanol were most effective at killing 99% of FCV-F9 
after 1 min of exposure (Malik et al., 2006). Similarly, Gehrke and others (2004), using 
quantitative suspension assays, suggested that 67% ethanol had a high degree of efficacy on 
decontaminating FCV-F9 after 1 min contact time (Gehrke et al., 2004). Macinga and others 
(2008) found that, using an infectivity assay, 70% ethanol could inactivate FCV-F9 by ≥4.75 
log10 PFU/mL after a 30 s contact time (Macinga et al., 2008). Belliot and others (2008) found 
that MNV-1 was significantly inactivated (>4 log PFU/mL) by 60% ethanol after 30 s exposure, 
as evaluated by plaque assays and real-time RT-PCR (Belliot et al., 2008). Similarly, Magulski 
and others (2009) observed ≥4 log reduction on MNV-1 with 50% ethonal after 5 min of 
exposure using an infectivity assay (Magulski et al., 2009). Park and others (2010), using plaque 
assays, also suggested that ≥70% ethanol was able to inactivate MNV-1 by >3.6 log with contact 
times ranging from 1 min to 5 min (Park et al., 2010).  
On the other hand, many studies showed that ethanol was ineffective against HNoV 
surrogates. For example, D’Souza and Su (2010) using plaque assays found that treatment with 
70% ethanol was not effective in reducing the infectivity of both FCV and MNV at low (~5 log 
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PFU/mL) or high (~7 log PFU/mL) titers after 30 s or 1 min contact times (D'Souza and Su, 
2010). Park and others (2010) reported that 70% ethanol resulted in a 2.6 log reduction in FCV 
after 5 min exposure (Park et al., 2010). The findings of Duizer and others (2004) were similar, 
with FCV being inactivated <2 log after an 8 min exposure to 70% ethanol, and a 3 log-reduction 
after a 30 min exposure, as evaluated by infectivity plaque assays (Duizer et al., 2004). Doultree 
and others (1999) also reported that FCV was not significantly inactivated (1.25 log) at ethanol 
concentrations of 75% with a contact time of 1 min (Doultree et al., 1999), which were similar to 
the reports by Whitehead and McCue’s (2010), with FCV being reduced approximately 1.3 logs 
after 1 min of exposure to 60-75% ethanol (Whitehead and McCue, 2010).  Lages and others 
(2008), using fingertips, found that ethanol concentrations of 99.5% was more effective (≥1 log 
reduction) than 62% ethanol (<1 log reduciton) against FCV-F9 with contact times of 30s or 2 
min, respectively (Lages et al., 2008).  
Other alcohols, including 1-propanol and isopropanol, were also used to reduce FCV-F9 
and MNV-1 (Table 1.2 and 1.3). For example, Gehrke and others (2004) reported that 50% to 
70% of 1-propanol was effective at inactivating FCV-F9 within 30 s, using a quantitative 
suspension assay. They found that 1-propanol at concentrations of 60% was the most effective, 
and 50% and 70% of 1-propanol could reduce FCV-F9 by 4 log units (Gehrke et al., 2004). 
Using a surface test, Magulski and others (2009) reported that MNV-1 was inactivated ≥4 logs 
after a 5 min exposure to 30% 1-propanol, as evaluated by an infectivity assay (Magulski et al., 
2009).  
Isopropanol was shown to be effective at inactivating FCV-F9 and MNV-1(Belliot et al., 
2008; Gehrke et al., 2004; Malik et al., 2006; Park et al., 2010), although reports by Park and 
others (2010) showed almost no reduction of FCV-F9 by 50%, 70% or 90% of isopropanol after 
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1 min or 5 min exposure, as determined by plaque assays (Park et al., 2010). Other studies 
suggested that isopropanol has a high degree of efficacy in decontaminating FCV-F9. For 
instance, Gehrke and others (2004) found that 58% of isopropanol was most effective against 
FCV-F9 after 1 min of exposure, as evaluated by a quantitative suspension assay (Gehrke et al., 
2004). Similarly, Malik and others (2006) reported that using TCID50, 40% to 60% isopropanol 
was most effective, which could kill 99% of FCV-F9 within 1 min (Malik et al., 2006). 
Compared to FCV-F9, MNV-1 showed more resistance to isopropanol. Park and others (2010) 
reported that ≥70% of isopropanol reduced the infectivity of MNV-1 by ≥2.6 log units after 5 
min contact time, as evaluated by plaque assay (Park et al., 2010). Belliot and others (2008) 
observed >3.8 log reduction of MNV-1 after 30 s exposure to 60% isopropanol, as determined by 
infectivity assay (Belliot et al., 2008). Using surface testing, Magulski and others (2009) found 
that 60% isopropanol inactivated MNV-1 by 3.02 log units after 5 min contact time using 
infectivity plaque assays (Magulski et al., 2009).  
Glutaraldehyde 
Glutaraldehyde is an organic compound used to disinfect medical and dental equipment 
and also used as a preservative in industrial cleaning agents. Glutaraldehyde has been studied as 
a disinfectant agent against food-borne viruses and surrogates, including hepatitis A virus 
(HAV), rotavirus, FCV-F9 and MNV-1.  
Glutaraldehyde at low concentration has been shown to inactivate food-borne viruses. 
Passagot and others (1987) reported that a > 3 log10 reduction was achieved after 30 min of 
exposure using 0.10% glutaraldehyde and within only 3 min using 0.50% glutaraldehyde against 
HAV using TCID50 assays (Passagot et al., 1987). Mbithi and others (1990) found that 2% 
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glutaraldehyde reduced HAV by 99.9% after 1 min of exposure on contaminated stainless-steel 
disks (Mbithi et al., 1990). Jean and others (2003) observed that disinfectant containing 5% 
glutaraldehyde plus 10% quaternary ammonium was effective in inactivating HAV in solution 
after a 5 min of contact time, which could reduce HAV by 7.25 logs at the final concentration of 
3,000 ppm (Jean et al., 2003). Lloyd-Evans and others (1986) reported that 2% glutaraldehyde 
was also effective against human rotavirus (Lloyd-Evans et al., 1986). Glutaraldehyde was also 
found to effectively inactivate human norovirus surrogates, FCV-F9 and MNV-1. Using surface 
tests, D’Souza and Su (2010) found that 2% glutaraldehyde effectively inactivated both FCV-F9 
and MNV-1 at both low (~5 log PFU/mL) and high (~7 log PFU/mL) titers after 30 s or 1 min 
exposure times (D'Souza and Su, 2010). Malik and others (2006) reported that, after a range of 1 
to 10 min exposure to 2.6% glutaraldehyde, FCV-F9 was inactivated by more than 99.99% 
(Malik et al., 2006). Similarly, Magulski and others (2009) observed a ≥4 log reduction of 
MNV-1 treated by 2500 ppm glutaraldehyde within 5 min exposure time (Magulski et al., 2009). 
Furthermore, there were no significant differences in virus reduction under either dirty or clean 
conditions. Using suspension tests, Doltree and others (1999) observed complete inactivation of 
FCV-F9 with 0.5% glutaraldehyde after 1 min contact time (Doultree et al., 1999).  
Benzalkonium chloride:  
Benzalkonium chloride (BAC) belongs to the quaternary ammonium compound (QAC) 
group, which have been widely utilized in hand sanitizers (Moadab et al., 2001) and disinfectants 
for hard surfaces (Gradel et al., 2004) as well as for pharmaceutical preservatives (Marple et al., 
2004) due to its effectiveness in decontaminating a broad spectrum of bacteria, viruses and fungi 
in solutions (Bastiani et al., 1974; Belec et al., 2000; Jira et al., 1982). BAC at low 
concentrations is reported to be non-irritating, non-toxic, and non-corrosive to food contact 
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surfaces and thus can be safely used as a disinfectant in the food industry as a readily-used 
antimicrobial agent. As quaternary ammonium compounds are surface acting agents, the antiviral 
mechanism of BAC may have been due to the alterations in the surface components at, or 
adjacent to the attachment site, which interacts with the receptor on the surface of the host cell 
(Wood and Payne 1998).  
BAC at 512 ppm (0.512 mg/mL) is reported to be effective against methicillin-resistant 
Staphylococcus aureus (MRSA), Campylobacter, Salmonella, Escherichia coli O157:H7, 
Listeria monocytogenes and Pseudomonas aeruginosa after an exposure of 5 min in both 
suspension and surface tests (Riazi and Matthews, 2011). In addition to bacteria, studies have 
also shown that BAC has antiviral activity against canine coronavirus (Pratelli, 2007), respiratory 
syncytial virus, adenovirus, herpes simplex virus hominis type 2 and cytomegalovirus (Belec et 
al., 2000). In suspension tests, in the presence of organic load, BAC effectively inactivate 
enveloped viruses herpes simplex virus type 1 and human immunodeficiency virus type 1, as 
well as the non-enveloped human coxsackie virus at the concentration of 0.2% w/v after 1 min 
with initial viral titers of 106-107 PFU/TCID50 or syncytia-forming assay (SFU) (Wood and 
Payne 1998).  
Su and D’Souza (2012) reported that BAC at 0.2, 0.5, and 1 mg/mL reduced FCV-F9 and 
MNV-1 at low (~5 log10 PFU/mL) titers to undetectable levels after 2 h at room temperature in 
suspension tests; and high (~7 log10 PFU/mL) titers of FCV-F9 was reduced by 2.87, 3.08, and 
3.25 log10 PFU/mL and high titer MNV-1 was reduced by 1.55, 2.32, and 2.75 log10 PFU/mL 




Organic acids:  
Organic acids, including lactic acid, tannic acid, and peroxyacetic acid, have been used 
for inactivating human noroviruses and human enteroviruses and their surrogates. The acid 
mediated mechanisms leading to a loss of infectivity have not been completely understood, 
which is believed to result from the alterations of the virus capsid and nucleic acid (Cliver, 2009; 
Salo and Cliver, 1976). However, whether the antiviral effect was derived from the decrease in 
pH or the type of acid is still not clear. It appears that the inactivation of non-enveloped viruses 
is due to the denaturation of capsid proteins due to the decrease in pH (Rodger et al., 1977)  
Using suspension tests, Straube and others (2011) found that D, L-lactic acid at the 
concentration of 0.3% (PH 3.4-3.5) and 0.4% (PH 3.2-3.3) could cause significant titer 
reductions of FCV-F9 after 7 days of exposure at 20°C (Straube et al., 2011). Using an organic 
acid-based disinfectant containing 55 to 60% formic acid and 7% glyoxylic acid, Poschetto and 
others (2007) observed a ≥5 log10 reduction of FCV-F9 after 15 min contact time, estimated by 
cell culture or a 2 to 3 log10 reduction after 15 min or 60 min as determined by RT-PCR 
(Poschetto et al., 2007). However, the disinfectant efficacy was strongly reduced by the presence 
of fetal bovine serum (FBS) or feces. Baert and others (2009) reported that 250 mg/L 
peroxyacetic acid could obtain an additional 1-log reduction for MNV-1 on shredded iceberg 
lettuce, and its efficacy was not influenced by the presence of organic materials (Baert et al., 
2009). Fraisse and others (2011) found that 100 ppm of peroxyacetic-based biocide effectively 
inactivated FCV-F9 by 3.2 log units and MNV-1 by 2.3 log units on the lettuce leaves after 2 
min of contact time, as estimated by cell culture (Fraisse et al., 2011). Whitehead and McCue 
(2010) reported that one acid-based bathroom disinfectant containing 2.5% citric acid (pH 2.0) 
could reduce FCV-F9 by >3.17 log10 reduction after 1 min of exposure (Whitehead and McCue, 
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2010). Recently, Zhang and others (2011) found that tannic acid derived from Chinese medicinal 
herbs as an inhibitor in binding to histo-blood group antigens (HBGAs) receptors, which 
indicated that tannic acid may be a promising antiviral against HNoVs (Zhang et al., 2011). Su 
and D’Souza (2012) reported that tannic acid at 0.2 mg/mL reduced low titers (~5 log10 
PFU/mL) of FCV-F9 by 1.95 log and <1 logs of high titers (~7 log10 PFU/mL) of FCV-F9 after 2 
h of contact time at room temperature. They also reported that gallic acid at 0.1, 0.2, and 
0.4 mg/mL reduced low-titers of FCV-F9 by 2.50, 2.36, and 0.86 log10 PFU/mL, respectively 
with little effect against high-titer FCV-F9 under the same exposure time (Su and D'Souza, 
2012). Oh and others (2012) demonstrated that gallic acid in black raspberry (BRB) juice did not 
show any antiviral activity against FCV-F9 or MNV-1, though BRB exhibited high efficacy 
against these viruses. Acetic acid is the typical acid used with chitosan and is known to have 
antibacterial activity (Oh et al., 2012). Acetic acid has been found to be effective against bacteria 
such as Salmonella Typhimurium, Enterobacter sakazakii and Listeria monocytogenes (Alvarez-
Ordonez et al., 2009; Back et al., 2009; Vasseur et al., 1999). Davis and others (2012) found that 
chitosan dissolved in 1% acetic acid reduced phiX174 by 1.19-1.29, MS2 by 1.88-5.37, FCV-F9 
by 2.27-2.94, and MNV-1 by 0.09-0.28 log10 PFU/mL, respectively after incubation for 3 h at 37 
°C (Davis et al., 2012). Malic acid is a dicarboxylic acid which was first isolated from apple 
juice. Malic acid at 10% combined with 1% thiamine dilauryl sulfate was found completely 
inactivated E. coli O157: H7 on 10g of inoculated alfalfa seeds (Fransisca et al., 2012). Malic 
acid combined with citric acid and sodium laruryl sulfate showed antiviral activity against 
rhinovirus (Hayden et al., 1985). Humic acid is a principle component of humic substances, 
which naturally occurs as decomposed constituents of soil. Ansorq and Rochus (1978) found that 
humic acids inhibited Staphylococcus epidermidis, S. aureus, Streptococcus pyogenes, S. 
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Typhimurium, P. vulgaris, E. cloacae, P. aeruginosa and C. albicans (Ansorg and Rochus, 
1978). Certain modified forms of humic acid have also shown antiviral activities against herpes 
simplex and human immunodeficiency viruses (Klocking et al., 2002; Schneider et al., 1996; 
Van Rensburg et al., 2002).  
Electrolyzed water 
Electrolyzed water (aka electrolyzed oxidizing water or EOW) is produced from the 
electrolysis of water containing sodium chloride. This procedure generates a solution of sodium 
hypochlorite, which is the active ingredient in household bleach. EOW has been applied in the 
food industry and agriculture due to its environmentally friendly nature, high efficiency, and no 
adverse side effects. EOW is believed to destroy the outer cellular membrane, increase the 
membrane permeability and decrease the activity of key enzymes due to its physical and 
chemical properties, including low pH, high oxidation-reduction potential, high dissolved 
oxygen and free chlorine (Koseki et al., 2001; Kuira and others 2002; Len et al., 2000; Liao et 
al., 2007; Park et al., 2004; Zeng et al., 2010). However, there is still no definite conclusion on 
the disinfection targets/and mechanisms of EOW.  
The acidic form of EOW was found to effectively inactivate food-borne pathogens on the 
food surfaces, including Escherichia coli, Staphylococcus aureus, Salmonella and Listeria 
monocytogenes. Park and others (2006) observed 2.41 and 2.65 log CFU reductions per lettuce 
leaf of E. coli O 157:H7 and L. monocytogenes respectively using acidic electrolyzed water (AC-
EW) (45 ppm residual chlorine) after 3 min of exposure time at 22℃ (Park et al., 2006). Koseki 
and others (2003) reported 4.6 and 4.4 log CFU/g reductions of E. coli O 157:H7 and S. 
Typhimurium respectively with the treatment of spot inoculated lettuce surfaces using 40 ppm 
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AC-EW for 1 min (Koseki et al., 2003). Guentzel and others (2008) showed that dip treatment of 
inoculated spinach and lettuce surfaces with 20 and 50 ppm AC-EW for 10 min resulted in 2.14 
to 4.97 log CFU/g reductions of E. coli, S. Typhimurium, and L. monocytogenes (Guentzel et al., 
2008). Park and others (2008) reported that E. coli O 157:H7, S. Typhimurium, and L. 
monocytogenes were reduced below the detection limit (0.7 log) after a 3-min treatment of AC-
EW (~37.5 mg/L) at room temperature on the surfaces of lettuce and spinach (Park et al., 2008).  
Slightly acidic electrolyzed water (SAEW) was also reported to be effective towards 
inactivating these food-borne pathogens. Issa-Zacharia and others (2010) reported that SAEW 
containing 23 mg/L available chlorine effectively reduced the population of E. coli, S. aureus, 
and Salmonella spp. by 5.1, 4.8, and 5.2 log CFU/mL, respectively after 60 s of treatment (Issa-
Zacharia et al., 2010).  However, the efficacy of AC-EW could be decreased by the presence of 
organic matter. Park and others (2009) evaluated the effects of bovine serum on the bactericidal 
activity of AC-EW on E. coli, S. Typhimurium, and L. monocytogenes inoculated surfaces of 
green onions and tomatoes. They showed that AC-EW (~37.5 mg/l available chlorine 
concentration) treatment alone achieved the reductions below the detection limit (0.7 log CFU/g) 
after 3 min, whereas the bactericidal activity decreased with the increase of bovine serum 
concentration (Park et al., 2009).  
EOW was also studied for the removal of inoculated human norovirus from the surfaces 
of raspberries and romaine lettuce by a simple wash. Tian and others (2011) found that an AC-
EW wash enhanced the binding of HNoV to raspberries and lettuce with only ~7.5% and ~4% of 





Ozone is a powerful oxidizing agent, which has been used as a disinfectant for killing 
microorganisms in air and water sources. Ozone applications in the food industry typically 
include decontamination of product surfaces and water treatment (Kim et al., 1999). The 
mechanism of inactivation of viruses may be due to both viral RNA and capsid protein 
destruction (Kim and others, 1999). Roy and others (1981) believed that damage to the viral 
nucleic acid was the major cause of poliovirus 1 inactivation by ozone (Roy et al., 1981). This is 
supported by the report of Shin and Sobsey (2003), which showed that virus reductions of 
poliovirus 1and coliphage MS2 exposed to ozone were similar as evaluated by both RT-PCR and 
infectivity assays (Shin and Sobsey, 2003). However, others suggested that ozone actually 
targets the capsid protein. Kim and others (1980) found that ozone breaks the protein capsid into 
subunits, which leads to the inactivation of bacteriophage f2 (Kim et al., 1980). This is evidenced 
by the study of Lim and others (2010), who reported that ozone at 1 mg/liter (at pH of 7 or 5.6 
and temperature of 20℃ or 5℃) effectively inactivated more than 99% of MNV-1 within 2 
min, as measured by plaque assays, but RT-PCR assay significantly underestimated the 
inactivation of MNV-1 (Lim et al., 2010).  
Ozone has shown its efficacy on the inactivation of norovirus surrogates, including FCV-
F9 and MNV-1. Hirneisen and others (2011) observed >6 log TCID50/mL of FCV reduction in 
water and ~2 log TCID50/mL on green onions and lettuce after 5 min of 6.25 ppm ozone 
treatment. MNV-1 inoculated onto these produce items produced a >2 log reduction after 1 min 
of exposure, as determined by plaque assay (Hirneisen et al., 2011). Hudson and others (2007) 
reported that ozone gas, at the level of 20-25 ppm, was able to reduce the concentration of 
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infectious FCV by a factor of more than 103 within less than an hour of exposure (Hudson et al., 
2007).  
Hydrogen peroxide:  
Hydrogen peroxide (H2O2) is also a strong oxidizer, which is often used as a bleaching or 
cleaning agent. Hydrogen peroxide has shown to be effective against enteric viruses and their 
surrogates. For example, Li and others (2011) found that liquid H2O2 (L-H2O2) at concentrations 
of 2.1% inactivated MNV-1 and coliphage X174 on stainless steel discs by approximately 4 log10 
units within 10 min, whereas for Bacillus fragilis Phage B40-8, 15% of L-H2O2 was needed to 
obtain a similar reduction in 10 min, with only a <1 log10 unit reduction after 5min of exposure 
to 2.52% of Vaporized H2O2 was achieved for the tested model viruses (Li et al., 2011). Tuladhar 
and others (2011) reported that hydrogen peroxide vapor at 127 ppm completely inactivated 
poliovirus, rotavirus, adenovirus and murine norovirus after 1 h treatment at room temperature 
on carriers (Tuladhar et al., 2011). Bentley and others (2011) observed a 4 log reduction on all 
tested surfaces within 20 min of exposure to 30% (w/w) H2O2 vapour. The reduction was 
achieved most rapidly on vinyl flooring (10 min), while the longest was observed on stainless 
steel (20 min). For glass, ceramic tile and plastic surfaces, the desired reduction titer was reached 
within 15 min (Bentley et al., 2011). Malik and others (2006) found that a combination of 2% 
sodium bicarbonate with 2% hydrogen peroxide killed FCV-F9 by 99.00% in 1 and 3 min, and 
99.68% of the virus was killed after 10  min contact time on stainless steel coupons (Malik and 





Potassium monosulfate:  
Potassium monosulfate (KPMS) is widely used as a powerful oxidizing agent. Currently, 
KPMS is routinely used in swimming pools against Escherichia coli to keep the water clean and 
safe (Anipsitakis et al., 2008). It has also been used as a mist in veterinary hospitals to 
decontaminate S. aureus and S. Typhiumurium by >99.9999% with the concentration of 4% for 
30 min exposure time after misting was completed (Patterson et al., 2005). In a 6-year study, 
KPMS at concentrations of 1 and 10 mg/mL completely inactivated S. aureus, MRSA and 
Pseudomonas aeruginosa after 10 and 2 min exposure times, respectively and no significant 
variation in resistance to KPMS was observed during the period of the study (Giacometti et al., 
2005). However, only a few studies reported the application of KPMS for viral inactivation. The 
KPMS-based product Virkon S was shown to completely inactivate the poultry enteric mortality 
syndrome (PEMS)-associated astrovirus in an embryo model (Schultz-Cherry et al., 2001). Also, 
KPMS was shown to completely inactivate FCV after 10 min of exposure (Eleraky et al., 2002). 
However, this study used only FCV from animal isolates and not the HNoV surrogate strains 
FCV-F9 or MNV-1. 
Solomon and others (2009) reported that Virkon at 1% containing 5 mg/mL KPMS 
reduced FCV-F9 from 4-5 log10 PFU/mL to undetectable levels after 10 min (Solomon et al., 
2009). Su and D’Souza (2012) reported that KPMS at 5, 10, and 20 mg/mL reduced high and 
low titers of FCV-F9 and low titers of MNV-1 to undetectable levels, while high titers of MNV-
1 were reduced by 0.92 and 3.44 log10 PFU/mL with KMPS at 5 and 10 mg/mL, respectively 




Trisodium phosphate  
Trisodium phosphate (TSP) is considered a generally recognized as safe (GRAS) 
chemical by the Food and Drug Admiminstration (FDA: Lindsay 1985), which has a pH of 12 in 
a 1% solution. TSP has shown efficacy against a wide range of pathogens, including E. coli 
O157: H7, Salmonella, poliovirus 1 and bacteriophages. Jerzy and others (2003) reported that 
significant reductions of bacteriophage MS2 and Poliovirus 1 were obtained by using 1.0% TSP 
solution on strawberries (Jerzy et al., 2003). TSP has also been evaluated as a detergent against 
norovirus surrogates, including FCV-F9 and MNV-1. D’Souza and Su (2010) reported that 5% 
TSP effectively inactivated high titers of MNV-1 and FCV by ≥6 log PFU/mL, and with a 5 log 
reduction of low viral titers after 30s or 1 min of contact time. TSP at 2% inactivated high titers 
of FCV by ≥6 log PFU/mL, but only a 1.05 log reduction for MNV-1 after 1 min exposure., 
while1% TSP reduced FCV by ~2.65 log PFU/mL, with no reduction of high titers of MNV-1 
(D'Souza and Su, 2010). Su and D’Souza (2011) found that 2% and 5% TSP reduced low titers 
of FCV to undetectable levels after 15 s or 30 s. Low titers of MNV-1 was reduced by ~2 - 3 log 
PFU/mL by 2% TSP and to undetectable levels by 5% TSP. High titers of FCV and MNV-1 
were reduced by > 5 or ~ 2- 3.4 log PFU/mL with 2% TSP, respectively, and to undetectable 
levels with 5% TSP (Su and D'Souza, 2011).  
Sodium metasilicate:  
Sodium metasilicate is a highly soluble chemical with the pH of a 1% solution ranging 
from 12.5 to 13.0. Sodium metasilicate is USDA FSIS approved as a processing aid and can be 
used as an antimicrobial component of marinades for meat and poultry products up to 2% by 
weight of the marinades and as a carcass rinse or spray on raw beef carcasses, subprimals, and 
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trimmings up to 6% in solution (USDA FSIS, 2011). Sodium metasilicate has been effective 
against E. coli O157: H7 and Salmonella both in vitro and in beef trimmings (Carlson et al., 
2008; Geornaras et al., 2012; Pohlman et al., 2009; Weber et al., 2004), Campylobactor jejuni 
and Salmonella Typhimurium in fresh chicken breast meat (Sharma et al., 2012a, b). Weber and 
others (2004) found that sodium metasilicate at 0.6% (pH 12.1) resulted in complete inhibition of 
E. coli O157: H7 after 5 to 10 s exposure in water at room temperature (Weber et al., 2004). 
Carlson and others (2008) reported that 4% sodium metasilicate (23oC, pH 12.94) reduced E. coli 
O157: H7 and Salmonella by ~1.9 and ~ 2.6 log CFU/mL, respectively from inoculated beef 
hides following a 30 s- spray- 2 min- dwell- 30 s - water rinse procedure (Carlson et al., 2008). 
Pohlman and others (2009) demonstrated that E. coli and Salmonella Typhimurium were reduced 
by ~1 log to ≥1.5 log CFU/mL, respectively, treated with 4% sodium metasilicate from 
inoculated beef trimmings (Pohlman et al., 2009). Geornaras and others (2012) compared the 
efficacy of sodium metasilicate against E.coli O157:H7 and 6 non-O157 Shiga toxin-producing 
E. coli (nSTEC) serogroups suggesting similar effectiveness. The initial pathogen counts were 
decontaminated by 1.3 to 1.5 log CFU/cm2 from inoculated beef trimmings after immersion for 
30 s in solution of 4% sodium metasilicate (pH 12.5) (Geornaras et al., 2012). Adler and others 
(2011) observed that brine solution containing 2.2% sodium metasilicate immediately reduced 
E.coli O157:H7 by ≥2.4 log CFU/mL (0 h) (Adler et al., 2011).  
Sodium metasilicate has also been evaluated for efficacy against viral pathogens, 
including human rotaviruses and vesicular stomatitis viruses (Springthorpe et al., 1986; Wright, 
1970). Springthorpe and others (1986) tested the efficacy of 69 commercial and 7 non-
commercial disinfectant formulations against human rotaviruses and found that the efficacy of 
quaternary ammonium-based disinfectant formulations was greatly improved by adding 0.5 to 
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5% sodium metasilicate. They believed that quaternary ammonium compounds and sodium 
metasilicate may act in an additive or synergistic manner to inactivate human rotaviruses 
(Springthorpe et al., 1986). However, Wright (1970) demonstrated that sodium metasilicate at 
5% (pH 12.1) was not viricidal against vesicular stomatitis virus after 10 min contact time 
(Wright, 1970).  
Natural antimicrobial extracts:  
As the global consumer’s demand for natural ingredients to reduce pathogenic 
microorganism from foods is steadily increasing, the investigation of the effectiveness of 
potential natural antimicrobials is necessary. Some natural extracts such as Cranberry juice and 
cranberry proanthocyanidins, Black raspberry juice, Grape seed extract, Pomegranate juice and 
pomegranate polyphenols, Hibiscus sabdariffa have shown antibacterial and antiviral activities.  
Cranberry extracts have been reported to have antibacterial activity against E. coli O157: 
H7, Salmonella Typhimurium, Listeria Monocytogenes, Helicobacter pylori and Staphylococcus 
aureus (Matsushima et al., 2008; Nogueira et al., 2003; Wu et al., 2008). In addition to 
antibacterial property, they have also shown antiviral activity against reovirus, bacteriophages 
T4, phiX-174 and MS2, rotavirus, influenza virus and human norovirus surrogates (Lipson et al., 
2007; Su et al., 2010a; Su et al., 2010b; Weiss et al., 2005). The mechanism of cranberry extracts 
on the antimicrobial activity has not been well established. Wu and others (2008) believed that 
both low pH and phenolics may cause the antibacterial effect by observing cell wall and cell 
membrane damage treated with cranberry concentrate, which may make bacteria vulnerable to 
cranberry concentrate (Wu et al., 2008). Similarly, cranberry extracts may injure the viral capsid 
structure or viral nucleic acid to interfere with viral replication. Su and others (2010a) reported 
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that FCV-F9 at ~ 5 log10 PFU/mL was reduced to undetectable levels after 1h of exposure to 
cranberry juice (CJ) (pH 2.6) or 0.15, 0.30, and 0.60 mg/mL cranberry proanthocyanidins (PAC) 
at room temperature. MNV-1 was reduced by 2.06 log10 PFU/mL with CJ, and 2.63, 2.75, and 
2.95 log10 PFU/mL with the three tested PAC solutions, respectively (Su et al., 2010a). In  
another time- dependent study by these investigators, FCV-F9 at low viral titers was  reduced by 
~5 log10 PFU/mL within 30 min treated by CJ (pH 2.6 and pH 7.0) and the two PAC solutions 
(0.15, 0.30 mg/mL). MNV-1 titers were decreased similarly with CJ at pH 2.6 or 7.0. In most 
cases, viral reduction within the first 10 min of treatment accounted for 50% of the total 
reduction (Su et al., 2010b).  
Pomegranate juice and pomegranate polyphenols exhibited a wide range of antioxidant, 
anticancer, anti-inflammatory and antimicrobial properties (Braga et al., 2005; Haidari et al., 
2009; Kotwal, 2008; Lee et al., 2010; Neurath et al., 2005; Prashanth et al., 2001; Reddy et al., 
2007). Pomegranate extracts have shown antibacterial activities against Salmonella 
Typhimurium, Staphylococcus aureus, E. coli, and Bacillus subtilis (Braga et al., 2005; 
Prashanth et al., 2001). They are also reported to have antiviral properties against influenza virus, 
HIV-1, poliovirus, herpes virus, poxvirus, and human norovirus surrogates (Haidari et al., 2009; 
Jayaprakasha et al., 2006; Konowalchuk and Speirs, 1976; Kotwal, 2008; Neurath et al., 2005; 
Su et al., 2010c, 2011). These antiviral effects were attributed to the high content of polyphenols, 
which were believed to act directly on the viral particles to block the attachment of the viruses to 
the cell receptors (Haslam, 1974). Pomegranate juice and pomegranate polyphenols were shown 
to cause 2.56, 1.32, and 0.32 log reduction for low titers of FCV-F9, MNV-1, and MS2, 
respectively, after treatment by pomegranate juice for 1 h at room temperature. The effects were 
decreased using high titers of three tested viruses. Pomegranate polyphenols at 8, 16, 32 mg/mL 
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were shown to reduce both low and high titers of FCV-F9 to undetectable levels within 1 h. 
MNV-1 at low titers was reported to be reduced by 1.30, 2.31, and 3.61 log10 PFU/ mL and at 
high titers by 1.56, 1.48, and 1.54 log10 PFU/mL with three tested concentrations of PP, 
respectively, after 1 h by these investigators (Su et al., 2010c). According to the time-dependent 
study carried out by Su and others (2011), PJ and PP were found as rather rapid acting, resulting 
in  50% reduction within the first 20 min of treatment for all tested viruses. FCV-F9 and MNV-
1 at titers of ~ 5 log10 PFU/mL were reduced by 3.12 and 0.79 log10 PFU/mL, respectively, using 
PJ within the first 20 min. Titer reductions of 4.02 and 0.68 log10 PFU/mL with 2 mg/mL PP and 
5.09 and 1.14 log10 PFU/mL with 4 mg/mL PP were reported by these investigators for FCV-F9 
and MNV-1, respectively, after 20 min (Su et al., 2011).   
Hibiscus sabdariffa are prepared as hot and cold beverages worldwide, and is classified 
as a GRAS  ingredient for the food industry (CDC 2006). In addition, aqueous extracts of 
Hibiscus sabdariffa have been used in folk medicine in the treatment of hypertension (Odigie et 
al., 2003; Olaleye, 2007; Wang et al., 2000). Hibiscus anthocyanins, a group of phenolic natural 
pigments present in calyces, have been found to have cardioprotective, hypocholesterolemic, 
antioxidative and heaptoprotective effects in animals (Chen et al., 2003; Jonadet et al., 1990; 
Wang et al., 2000). Moreover, the aqueous extracts were reported the presence of hibiscitrin, 
gossypitrin, sabdaritrin, flavonol glycosides and some organic acids including citric, malic, 
tartaric and ascorbic (Ali et al., 2005; Cowan, 1999; Tsai et al., 2002). Aqueous extracts of H. 
sabdariffa have exhibited a wide range of antimicrobial properties against Pasteurella, 
Pseudomonas, Proteus, Streptococcus, P. aeruginosa, Lactobacillus sp., Bacillus sp., 
Corynebacterium sp., Salmonella, Escherichia coli O157:H7 And Listeria monocytogenes (Oboh 
and Elusiyan, 2004; Pliego, 2007; Sharaf et al., 1966). The mode of action includes phenols that 
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inhibit metabolic enzymes of the cells leading to their inability to reproduce. The phenolic 
compound, anthocyanins, extracted from Hibiscus sabdariffa were suggested to complex with 
nucleophilic amino acids of the cell wall, resulting the loss of function (Cowan, 1999; Tsai et al., 
2002). However, phenols may not be the only compound responsible for all the antimicrobial 
activities of Hibiscus sabdariffa. Roman (2006) found that rifamycine, a precursor of the 
antibiotic rifampicin, was present in Hibiscus sabdariffa extracts (Roman 2006).  
Based on the current literature, the aims of this research were to (1) investigate the 
antiviral activity of benzalkonium chloride at 0.32 mg/mL and KPMS against human norovirus 
surrogates over 1 h at room temperature using suspension and carrier tests and (2) determine the 
ability of sodium metasilicate to inactivate human norovirus surrogates at RT over 1 h for 
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Table 1.1： Examples of studies using chlorine against FCV-F9 and MNV-1 
 
 
NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 
TCID50= Tissue culture infectious dose 50%  
ss = stainless steel; ls = lettuce and strawberry 
Viruses Concentration Contact time Initial titer Reduction in log10 
PFU/mL 
Method Reference 




200 mg/L= 200 ppm 
(lettuce and pepper) 
5,000ppm (surface) 
 
300 ng/mL= 0.3ppm (suspension) 
100ppm, 1000ppm (surface) 
 
100, 1000 ppm (surface) 
 
200, 400, 800, 5000ppm (stainless 
steel, lettuce and strawberry) 
 
100, 250, 500, 1000 and 5000 ppm 
(suspension) 
4500-5000 ppm (suspension) 
5500 ppm 
 






15 s or 30 s 
 


















2 x 105~ 1 x 106 
TCID50/mL 
~5 log10 PFU/mL 
~7 log10 PFU/mL 
~5 log10 PFU/mL 
~7 log10 PFU/mL 
















>5 log units 
 









<800 ppm <1 (ss) 
5000 ppm 3.4 (ss) 
800 ppm 1.5 (ls)  
<500 ppm <3 
5000 ppm 5 
Without feces: >5  
With feces:  3 
 
3 






















Fraisse et al. 2011 
 
Duizer et al. 2004 
 
Su and D’Souza, 
2011 
D’Souza and Su 
2010 
Urakami et al. 2007 
Whitehead and  
McCue, 2010 
Jimenez and Chiang, 
2006 
Gulati et al., 2001 
 
 
Doultree et al., 1999 
 
Poschetto et al., 2007 
 
 




Table 1.1：Examples of studies using chlorine against FCV-F9 and MNV-1 (Continued)  
Viruses  Concentration  Contact time Initial titer Reduction in log10 
PFU/mL 
Method Reference  




0.26%= 2600 ppm 
 (suspension) 




5000ppm (fecally soiled 







15 s or 30 s 
 
5 min or 10 min 
 
3.2 min 






~5 log10 PFU/mL 















Plaque assay and qRT-
PCR 
Plaque assay and real-
time RT-PCR 




Plaque assay and real-
time RT-PCR 
Plaque assay 
Fraisse et al. 2011 
 
Kitajima et al. 2010 
 
Belliot et al. 2008 
 
Su and D’Souza 
2011 
Girard et al., 2010 
 
Park and Sobsey,  
2011 
 
NR= Not Reported  






Table 1.2: Examples of studies using ethanol, 1-propanol and 2-propanol against FCV-F9 and MNV-1 
 
 
NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 
TCID50= Tissue culture infectious dose 50%  
  





















50% or 70% 















30s or 2min 
4.5 log10 PFU/mL 
2 x 105~ 1 x 106 
TCID50/mL 
~5 log10 PFU/mL        
















Most effective, killing 























Fingerpad and Plaque 
assay 
Martino et al. 2010 
Duizer et al. 2004 
 
D’Souza and Su,  
2010 
Malik et al. 2006 
 
Gehrke et al. 2004 
 
Macinga et al. 2008 
Doultree et al. 1999 
Whitehead and 
McCue 2010 
Park et al., 2010 
Lages et al. 2008 
MNV-1  70% 





30s or 1min 
 
5min 
30s, 1min or 
3min 
5 min 
~5 log10 PFU/mL 





   0 
 
      ≥3.6 
      >4 
 




Plaque assay and RT-
qPCR 
Plaque assay 
D’Souza and Su. 
2010 
Park et al., 2010 
Belliot et al. 2008 
 
Magulski et al. 2009 
42 
 
Table 1.2: Examples of studies using ethanol, 1-propanol and 2-propanol against FCV-F9 and MNV-1 (Continued) 
Viruses Chemical Concentration Contact time Initial titer Reduction in 
log10 PFU/mL 
Method Reference 






Plaque assay Gehrke et al. 2004 
MNV-1  30% (surface) 5 min NR ≥4 Plaque assay Magulski et al. 
2009 
FCV-F9 2-propanol 40% to 60% 
 



















Malik et al. 2006  
 
Park et al., 2010 
Gehrke et al. 2004 
MNV-1  ≥70%  
60%  
 
60% (surface)  
5 min 












Plaque assay and 
qRT-PCR 
Plaque assay 
Park et al., 2010 
Belliot et al. 2008 
 
Magulski et al. 
2009 
 
NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 
TCID50= Tissue culture infectious dose 50%  
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NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 
TCID50= Tissue culture infectious dose 50%  
  
Viruses Concentration Contact time Initial titer Reduction in  log10 
PFU/mL 
Method Reference 
FCV-F9 2% (surface) 
 
0.5% (suspension) 
2.6% (fabrics and carpets) 




~5 log10 PFU/mL 
~7 log10 PFU/mL 










D’Souza and Su 
2010 
Doultree et al. 1999 
Malik et al., 2006 
MNV-1 2% (surface) 
 
2500ppm (stainless steel) 
30 s or 1 min 
 
5 min 
~5 log10 PFU/mL 








D’Souza and Su 
2010 
Magulski et al., 2009 
44 
 
Table 1.4: Examples of studies using organic acids against FCV-F9 and MNV-1 
 
 
NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 
RT-PCR= Reverse transcription- polymerase chain reaction 
 
  
Viruses Chemical Concentration Contact time Initial titer Reduction in  log10 
PFU/mL 
Method Reference 






Tannic acid  
 
Gallic acid 








0.1, 0.2, and 0.4 mg/mL 
15 min 
15 min or 60 min 




































Poschetto et al., 2007 
 




Su and D’Souza, 
2012 
MNV-1 Peroxyacetic acid 
(lettuce leaves) 
100 ppm           2 min NR 
 
2.3 Plaque assay 
 
Fraisse et al., 2011 
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Table 1.5: Examples of studies using ozone and hydrogen peroxide against FCV-F9 and MNV-1 
 
 
NR= Not Reported  
qRT-PCR= Quantitative reverse transcription- polymerase chain reaction 




Viruses Chemical Concentration Contact time Initial titer Reduction in  log10 
PFU/mL 
Method Reference 
FCV-F9 Ozone 6.25 ppm (water) 
6.25 ppm (produce) 
20- 25 ppm  
5 min 
 




>6 log TCID50/mL 






Hirneisen  et al. 
2011 
Hudson  et al. 
2007  
MNV-1  1 mg/liter  






   >2 log TCID50/mL 
TCID50 
TCID50 
Lim et al. 2010 




V- H2O2 30% (w/w) 
(carriers) 
20 min NR 4    Plaque assay Bentley et al. 2011 
MNV-1  L-H2O2 2.1% (stainless 
steel) 














Li et al. 2010 
 




Table 1.6: Examples of studies using trisodium phosphate against FCV-F9 and MNV-1 
 
 
NR= Not Reported  



















15 s or 30 s 
~ 7 log10 PFU/mL 
 
 
~ 5 log10 PFU/mL 
 
 
~ 7 log10 PFU/mL 
 
~ 5 log10 PFU/mL 
 
             ~ 2.65 
≥6 
≥6 
               ~ 5 
        ~ 5 
        ~ 5 
>5 
To undetectable levels 
To undetectable levels 




























~7 log10 PFU/mL 
 
 
~ 5 log10 PFU/mL 
 
 
~ 7 log10 PFU/mL 
 
~ 5 log10 PFU/mL 
0 





~ 2 – 3.4 
To undetectable levels 
~ 2 - 3 















Su and D’Souza, 2011 
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Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter  
Chemicals Advantages Disadvantages Applications References 
Chlorine 
















Household cleaning products; 









Long contact time 
required; not 
effective against 
some viruses and 
bacterial spores; 
evaporate quickly 









spores and parasites; 
remains effective in 
the presence of 
organic matter 
Toxic to human and 
animals; long 
contact time; must 
be used in a well 
ventilated area 
Disinfecting medical and dental 
equipment; industrial water 
treatment; preservertive 




Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter 
(Continued)  




skin; not corrosive; 
has been used for 
decades in hospital 
environment 
Slow- acting; not 
effective against 
gram-negative 
bacteria or spores 
Non-alcohol-based hand 
sanitizers; hard surface 
disinfectants;  surgical 
instrument sterilizing solutions; 





Less reaction with 
organics; wider pH 
range; no toxic 
residues 
Not effective against 
spores 
Disinfecting surfaces; red meat 
carcass spray; fruits and 
vegetables 




Kill spores and many 
viruses and bacteria; 
On-site production 
of disinfectant; can 
be applied directly 
on fresh food 
products 
Lose potency fairly 
quickly; equipment 
costly 
Disinfectant on food contact 
surfaces, fruits and vegetables 





viruses and fungi 
Inactivation by 
organic matter; 10 
ppm can be harmful 
to human health 
Sanitizers; process water; 
products (fruits, vegetables and 
juices); gas (control mold in 
storage) 




Table 1.7: Advantages, disadvantages and applications of disinfectants reviewed in this chapter 
(Continued) 






agent; no toxic 
residues 







damaging to tissues; 
moderately 
corrosive; 
ineffective in the 
presence of organic 
matter 
Skin antiseptic; disinfectant; 
chemical sterilant 









Approved by FDA 
to be a GRAS 
chemical; 
Relatively high cost 
compared to 
chlorine 
Cleaning agent; approved for 





Approved by USDA 
FSIS to be used in 
food; no adverse 
effect in food 
Relatively high cost 
compared to 
chlorine 
Processing aid as an antimicrobial 
in marinades for meat products; a 
carcass rinse or spray on beef 
















Figure 1.1: Chemical structures of disinfectants evaluated in this work. Panel A- benzalkonium 
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Human noroviruses, the major cause of acute nonbacterial gastroenteritis worldwide, are 
easily transmitted via person-to-person and contaminated food-contact surfaces. This research 
determined inactivation of human norovirus surrogates, feline calicivirus (FCV-F9) and murine 
norovirus (MNV-1), by benzalkonium chloride (BAC) and potassium peroxymonosulfate 
(KPMS) over 1 h at room temperature using suspension and carrier (stainless-steel coupons) 
tests.  Virus recovery after triplicate treatments was evaluated using infectious plaque assays and 
compared to controls. In suspension tests, 0.32 mg/mL BAC caused 1.94 and 2.59 log PFU/mL 
reductions of FCV-F9 at low and high titers after 1 h, respectively; and > 3 and 1.47 log 
reduction of MNV-1 at low and high titers, respectively. KPMS at 5 and 10 mg/mL reduced both 
viruses at low titers within 30 s and high titers of FCV-F9 to undetectable levels after 2 min and 
30 s, respectively. KPMS at 5 mg/mL had little effect against high titers of MNV-1, though 10 
mg/mL KPMS caused a 4.61 log reduction after 5 min. Using carrier tests, KPMS at 5 and 10 
mg/mL reduced both viruses at low titers after 30 s.  High titers of FCV-F9 and MNV-1 required 
10 mg/mL KPMS for 10 and 15 min, respectively for complete inactivation. Carrier tests with 
0.32 mg/mL BAC reduced low titers of both viruses to undetectable levels after 1 h without 
significant reduction of high titers even after 2 h; simulated dirty conditions showed decreased 
viral reduction. These results indicate that KPMS causes viral reduction within short contact 




Human noroviruses (HNoVs) are considered as the most common cause of acute non-
bacterial gastroenteritis in the world, that are currently responsible for approximately 90% of 
non-bacterial enteric outbreaks (Scallan et al., 2011; Siebenga et al., 2009; Lindesmith et al., 
2003). These viruses can be transmitted via contaminated water, food, surfaces, or through direct 
contact with infected persons (Goodgame et al., 2006). HNoVs are quite persistent in the 
environment being detected on food-contact surfaces for up to 7 days at room temperature 
(D'Souza et al., 2006; Liu et al., 2009). They can persist in water and foods, such as marinated 
mussels, lettuce, green onions, strawberries and ready-to-eat products for several days (Bidawid 
et al., 2004; Green et al., 1998, 1999; Hewitt and Greening, 2004). Although, HNoV infection 
itself is self-limiting in healthy individuals, they can be life-threatening to the elderly and 
immunocompromised (Siebenga et al., 2009; Donaldson et al., 2010). HNoV outbreaks result in 
economic losses from product recalls or public health costs, as well as loss of labor due to 
inability of employees to report to work. Outbreaks related to cruise-ships, nursing homes, and 
elderly care facilities continue to be reported annually (Cheesbrough et al., 2000; Anderson et al., 
2001; Center for Disease Control and Prevention, 2002; Scallan et al., 2011).  
Since HNoVs cannot be cultivated in the lab, cultivable surrogates including feline 
calicivirus, FCV-F9 and murine norovirus, MNV-1, are used to determine efficacy of 
inactivation using infectivity plaque assays. Currently, chemical disinfectants that are utilized for 
HNoV decontamination include chlorine, sodium hypochlorite (household bleach), 
glutaraldehyde, and other quaternary ammonium compounds (Jimenez and Chiang, 2006; Jean et 
al., 2003; Solomon et al., 1998). These chemicals are reported to be effective on contact surfaces 
against FCV-F9 and MNV-1 (Park and Sobsey, 2011; Duizer et al., 2004; D’Souza and Su, 
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2010). However, some of the disadvantages of these chemicals include their corrosive nature that 
can cause damage to equipment including rust and staining of surfaces and are harmful during 
handling. Also, carcinogenic byproducts can be formed by the interaction of chlorine with 
organic matter (Dunnick and Melnick, 1993). Therefore, it is important to explore alternative 
chemical disinfectants to effectively inactivate HNoVs that have a broad range of antimicrobial 
activity against nosocomial infections. 
Benzalkonium chloride (BAC) is a chemical that has been used in hospital environments 
for surface disinfection and decontamination against a wide range of pathogenic bacteria. BAC at 
512 ppm (0.512 mg/mL) is reported to be effective against methicillin-resistant Staphylococcus 
aureus (MRSA), Campylobacter, Salmonella, Escherichia coli O157:H7, Listeria 
monocytogenes and Pseudomonas aeruginosa after an exposure time of 5 min in both suspension 
and surface tests (Riazi and Matthews, 2011). In addition to bacteria, studies have also shown 
that BAC has antiviral activity against canine coronavirus (Pratelli, 2007), respiratory syncytial 
virus, adenovirus, herpes simplex virus hominis type 2 and cytomegalovirus (Belec et al., 2000). 
Potassium peroxymonosulfate (KPMS) is another chemical that is routinely used in swimming 
pools to keep the water clean, and is effective against Escherichia coli after 1 h at a dose of 25 
ppm (0.025 mg/mL) (Anipsitakis et al., 2008). Previous studies have also shown its effectiveness 
against veterinary isolates of FCV and the poultry enteritis mortality syndrome-associated 
astrovirus (Eleraky et al., 2002; Schultz-Cherry et al., 2001). Therefore, routinely used chemical 
disinfectants for bacterial disinfection in these facilities may also have the potential to inactivate 
HNoVs and/or HNoV surrogates to prevent their spread.   
With the alarming increase in HNoV outbreaks and their emerging virulent forms such as 
GII.4 that are known to cause death in the elderly and immune-compromised (Siebenga et al., 
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2010), it has become imperative to implement improved control strategies in high risk areas 
including hospitals, elderly-care facilities, cruise-ships, and the food environment.  
Previously, using suspension tests, it was shown that BAC (0.2, 0.5, and 1 mg/mL) and 
KPMS (5, 10, and 20 mg/mL) can reduce the titers of FCV-F9, MNV-1, and bacteriophage MS2 
after 2 h at room temperature (Su et al., 2012). In this study, the time-dependence effects of 
benzalkonium chloride (BAC at 0.32 mg/mL) and potassium peroxymonosulfate (KPMS at 5 
and 10 mg/mL) against FCV-F9 and MNV-1 over 1 h at room temperature were compared in 
vitro using suspension tests and carrier tests on stainless-steel coupons under clean and simulated 
dirty conditions. The infectivity after treatment was evaluated by using infectious plaque assays 
and compared to control (water-treated) viruses.  
 
                                                            Materials and Methods 
Virus Stocks  
Feline calicivirus (FCV-F9) and its host, Crandell Reese Feline Kidney (CRFK) cells, 
were obtained from American type culture collection (ATCC) (Manassas, VA). Murine 
norovirus (MNV-1) was kindly provided by Dr. Skip Virgin (Washington University, St. Louis, 
MO), and its host, RAW 264.7 cells were obtained from the University of Tennessee cell culture 
collection. Viral stocks were obtained as previously described using their respectively confluent 
cell lines in 175cm2 flasks (D’Souza et al., 2011; Su et al., 2011). Viral titer was quantified using 






Chemicals and Treatments  
Benzalkonium chloride (BAC), obtained from MP Biomedicals (Illkirch, France), was 
diluted with sterile de-ionized water to reach a concentration of 0.32 mg/mL and then filter-
sterilized with a 0.2 μm filter (Fisher Scientific, GA, USA). Potassium peroxymonosulfate 
(KPMS) (Tokyo Chemical Industry Co., Japan) was prepared in sterile de-ionized water to reach 
final concentrations of 5 and 10 mg/mL and filter-sterilized with a 0.2 μm filter (Fisher 
Scientific, GA, USA).  
For the suspension test, one volume (167 µl) of BAC and KPMS were mixed with an 
equal volume of FCV-F9 or MNV-1 at high and low titers of ~7 log10 PFU/mL and ~5 log10 
PFU/mL to obtain a final concentration of 0.16 mg/mL BAC or 2.5 mg/mL and 5 mg/mL KPMS, 
respectively, and incubated for specific time intervals of 0, 5, 10, 15, 30 and 60 min at room 
temperature (22oC). For the carrier test, stainless steel coupons sterilized by autoclaving were 
used as a surface model (fomite). Under clean conditions, MNV-1 and FCV-F9 were inoculated 
on sterile coupons at high and low titers of ~7 log10 PFU/mL and ~5 log10 PFU/mL and allowed 
to dry for 1 h at room temperature in a BioSafety Level 2 hood.  After drying, the coupons were 
treated with BAC or KPMS and sampled at specific time intervals of 0, 5, 10, 15, 30 and 60 min 
at room temperature (RT). Heat-inactivated fetal bovine serum (5% FBS, HyClone Laboratories, 
Inc, Logan, Utah) was added into the virus stocks to simulate an organic load to test the efficacy 
of chemicals against HNoV surrogates in the presence of dirty conditions using the same 
procedures as described above for clean conditions.  
Sterile water was used as non-treated controls to test the viral recovery and to compare 
with treated samples. All the chemical treatments were neutralized after their appropriate 
treatment contact times by serially diluting the virus-chemical mix in Dulbecco’s Modified 
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Eagle’s Medium/Ham’s F-12 (HyClone Laboratories, Inc, Logan, Utah) containing 10% heat-
inactivated FBS followed by serial dilutions in DMEM-F12 containing 2% FBS and plaque 
assayed as described below.  
 
Plaque Assays for FCV-F9 and MNV-1  
Serial dilutions (0.5 mL) of control and treated viruses were inoculated onto the confluent 
CRFK cells for FCV-F9 and RAW 264.7 cells for MNV-1 in 6-well plates, and incubated for 2.5 
h at 37℃ in a CO2 incubator. Plaque assays were performed as previously described (D’Souza et 
al., 2006; D’Souza et al., 2009; Su et al., 2011). Briefly, overlay medium containing 0.75% noble 
agar (Sigma-Aldrich, St. Louis, MO) was added to each infected or control well and incubated 
for 2~3 d at 37oC under 5% CO2. Finally, overlay media containing neutral red (Sigma-Aldrich, 
St. Louis, MO) was added for visualization of plaques after incubation.  
 
Statistical Analysis  
All treatment and controls were replicated thrice in duplicate. A one-way analysis of 
variance (ANOVA) was used to test for differences in means of plaque counts among treatments 
and means were analyzed using a completely randomized design at p<0.05 in SAS program 
(version 9.3, SAS Institute, Cary, NC, USA).  If statistically significant differences were found 








Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in suspension tests  
BAC at 0.32 mg/mL concentration for 5, 10 and 15 min contact time caused <1 log10 
PFU/mL reduction for FCV-F9 and MNV-1 at low titers, with ~1 log10 PFU/mL of reduction 
after 30 min, and with greater reduction of 1.94 log10 PFU/mL or ≥3 log10 PFU/mL for FCV-F9 
and MNV-1, respectively, after 1 h at RT. Using high viral titers, FCV-F9 and MNV-1 were 
reduced by ~1 log10 PFU/mL after 10 min of exposure time. FCV-F9 titer was reduced by 2.59 
log10 PFU/mL after 1 h, while a 1.47 log reduction was observed for MNV-1 at RT (Table 2.1).  
 
Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in suspension tests 
FCV-F9 and MNV-1 were undetectable after exposure to 5 or 10 mg/mL of KPMS after 
10 min (data not shown). Therefore shorter contact times for 0, 30 s, 1 min, 2 min and 5 min 
were further evaluated at the same concentrations of KPMS. Low titers of FCV-F9 and MNV-1 
were undetectable within 30 s. However, KPMS at 5 mg/mL reduced high titers of FCV-F9 by 
≥5 log10 PFU/mL after 2 min, but caused little reduction (~0.5 log) of high titers of MNV-1 after 
5 min of exposure time. Increasing the concentration of KPMS to 10 mg/mL for 30 s of contact 
time resulted in ≥5 log10 PFU/mL reduction for high titers of FCV-F9 and also had a significant 
effect on high titers of MNV-1 resulting in a 4.61 log reduction after 5 min at RT (Table 2.2).  
 
Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in clean coupon tests  
Since little reduction was achieved in the suspension test after 1 h of exposure and it is 
generally recognized that chemical efficacy is higher in suspension than carrier tests, longer 
contact times for BAC at a concentration of 0.32 mg/mL on stainless steel coupons were needed 
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for testing. Low titers of FCV-F9 and MNV-1 were reduced to undetectable levels after 1 or 2 h 
of exposure at RT. High titers of FCV-F9 were reduced by 1.45 and 1.05 log10 PFU/mL with the 
treatment of BAC after 1 h and 2 h, respectively. However, lower reductions of ~0.7 log10 
PFU/mL for high titers of MNV-1 were achieved after 1 or 2 h of exposure to 0.32 mg/mL of 
BAC at RT (Table 2.4).  
 
Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in clean coupon tests  
KPMS at 5 and 10 mg/mL concentrations reduced FCV-F9 and MNV-1 at low titers to 
undetectable levels within 30 s contact time. KPMS at 10 mg/mL concentration reduced high 
titers of FCV-F9 and MNV-1 by 1.92 and 1.56 log10 PFU/mL after 5 min, respectively; and 
complete inactivation was obtained after 10 min and 15 min for FCV-F9 and MNV-1, 
respectively. Lowering the concentration of KPMS to 5 mg/mL for 5 min of contact time only 
resulted in a <1 log reduction for high titers of FCV-F9 and MNV-1. FCV-F9 at high titers were 
reduced to undetectable levels after 10 min of exposure time to 5 mg/mL KPMS, while only 2.46 
log10 PFU/mL reduction was reached for MNV-1 after 1 h at RT (Table 2.3a).  
 
Reduction of FCV-F9 and MNV-1 by 0.32 mg/mL BAC in dirty coupon tests  
The effect of BAC at 0.32 mg/mL concentration was decreased significantly on FCV-F9 
and MNV-1 titer reduction after 1 or 2 h contact times under dirty conditions. Almost no 
reduction was observed on high titers of FCV-F9 and MNV-1 after 2 h of contact time. 
Furthermore, <0.5 log10 PFU/mL reduction was observed on low titers of FCV-F9 and MNV-1 




Reduction of FCV-F9 and MNV-1 by 5 and 10 mg/mL KPMS in dirty coupon tests  
KPMS at 5 mg/mL for 2 min effectively inactivated low titers of FCV-F9 and reduced 
MNV-1 to undetectable levels (Table 2.6). FCV-F9 at high titer was reduced to undetectable 
levels after 15 min of exposure time by 5 mg/mL of KPMS. High titers of MNV-1 were reduced 
by 2.29 logs after 1 h of contact time at RT, which was similar to the clean condition carrier 
tests. Increasing the concentration of KPMS to 10 mg/mL reduced FCV-F9 and MNV-1 at low 
titers to undetectable levels after 1 min and 30 s, respectively. High titers of FCV-F9 were 
reduced to undetectable levels after 10 min. However, the effect of KPMS on high titers of 
MNV-1 was decreased compared to the clean conditions, where only a 2.52 log10 PFU/mL 
reduction was achieved after 15 min of contact time and complete reduction was observed only 
after 1 h of exposure at RT (Table 2.3b).  
 
Discussion 
In this study, the effect of 0.32 mg/mL BAC and 5 and 10 mg/mL KPMS on the titer 
reduction of FCV-F9 and MNV-1 was evaluated. The virus reduction was found to be related to 
the contact time, contact surfaces, the type of virus and chemical disinfectant used. Generally, 
longer contact times resulted in increased reductions for both tested viruses. BAC required 
longer contact times to effectively inactivate both viruses, while KPMS was found to be a fast-
acting agent causing rapid reduction of viral titers within short contact times. Both chemicals had 
decreased efficacy for both tested viruses using the stainless-steel coupon tests compared to 
suspension tests that could be attributed to the interference of the physical properties of the 
surface with contact between the microorganisms and disinfectants (Best et al., 1988). Not 
61 
 
surprisingly, the effect of both chemical disinfectants was decreased in the presence of organic 
loads.  
Current chemical disinfectants routinely used include alcohols including ethanol, 1-
propanol, and 2-propanol, glutaraldehyde and sodium hypochlorite. Using suspension tests, 70% 
ethanol was most frequently tested by investigators, but without any conclusive suggestions on 
its effectiveness against HNoV surrogates (Martino et al., 2010; Malik et al., 2006a; Park et al., 
2010; D’Souza and Su, 2010; Duizer et al., 2004; etc.). Iso-1-propanol at 50% and 70% was 
reported to have >4 log reduction after 30 s of contact on FCV-F9, whereas 2-propanol was 
effective only after 3 min of contact time (Gehrke et al., 2004). In another study, 1-propanol at 
only 30% was shown to be the most effective virucidal agent among the three alcohols tested on 
stainless steel for MNV-1 with 99.99% reduction, followed by (50-55%) ethanol and then (60%) 
2-propanol (Magulski et al., 2009). Furthermore, this study showed the efficacy of 1000 ppm 
peracetic acid and 2500 ppm glutaraldehyde to inactivate 99.99% of MNV on the carriers within 
5 min of exposure time (Magulski et al., 2009). Using surface disinfection tests, 70% ethanol 
was reported to be ineffective against high as well as low titers of MNV-1 and FCV-F9 after 1 
min of contact time (D’Souza and Su, 2010). In comparison to ethanol, the results reported with 
BAC show higher effects though requiring longer contact time of 1 h. Typical sodium 
hypochlorite wash solutions were reported to be effective only at >300 ppm for HNoV 
inactivation, where complete inactivation of FCV-F9 was reported at chlorine levels of 3,000 
ppm (or higher) after 10 min at room temperature (Duizer et al., 2004). On the other hand, 2% 
glutaraldehyde was found to effectively reduce FCV-F9 and MNV-1 by ~6 log10 PFU after 30 s 
and 1 min of contact time, while 10% household bleach containing 5000 ppm free chlorine 
resulted in effective reductions of FCV-F9 by >6 log10 PFU/mL in 1 min, but failed to 
62 
 
completely inactivate MNV-1 (D’Souza and Su, 2010). These results are consistent with reports 
showing that MNV-1 is a sturdy and resilient virus, resistant to most treatments and processing 
conditions compared to FCV-F9.  One surface disinfection test was carried out on fabrics and 
carpets, to show that an activated dialdehyde-based product containing 2.6% glutaraldehyde 
could reduce more than 99.99% of FCV in 1-10 min on all types of material tested (Malik et al., 
2006b).  
Recently, Japanese investigators found that 1000 µg/mL copper iodide nanoparticles had 
an extremely high antiviral activity reducing FCV by 7 orders of magnitude after 1 h of contact 
time (Shionoiri et al., 2012). Furthermore, investigators suggested tannic acid derived from 
Chinese medicinal herbs inhibited binding to histo-blood group antigens (HBGAs) receptors in 
HNoVs, which indicated tannic acid a promising antiviral (Zhang et al., 2012). A novel MNV 
strain, MT30-2, was isolated from the feces of mice in Japan and two antiseptics, povidone-
iodine and sodium hypochlorite, revealed strong virucidal activity against MNV, which 
inactivated MNV at low concentrations and in short exposure time (Matsuhira et al., 2012).  
Quaternary ammonium compounds (QAC) have been studied as disinfectants against 
human NoVs and its surrogates including FCV-F9 and MNV-1. Previous studies using 
commercial cleansers that contain the active ingredient n-alkyl dimethyl benzyl ammonium 
chloride at 0.08%, showed less than 1 log of reduction for MNV-1 was obtained after 10 min at 
RT (Girard el at., 2010), and similar results were reported by others showing that QAC 
disinfectants were not effective against FCV-F9 (Doultree et al., 1999; Eleraky el at., 2002). 
Another commercial disinfectant with 1:10 final concentrations of QAC showed no reduction 
against FCV after 1 min (Doultree et al., 1998). QAC disinfectants containing 0.14% BAC was 
also shown to be ineffective at virolysis of human GII.4 norovirus (Nowak el at., 2011). 
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Similarly, our study showed that both high and low titer of FCV-F9 and MNV-1 reached ≤1 
log10 reduction by treatments with 0.32 mg/mL BAC after 10 min at RT, but required longer 
exposure/contact times for improved effects. 
BAC belongs to the QAC group, which have been widely utilized in hand sanitizers 
(Moadab et al., 2001) and disinfectants for hard surfaces (Gradel et al., 2004) and as 
pharmaceutical preservatives (Marple et al., 2004) due to its effectiveness in decontaminating a 
broad spectrum of bacteria, viruses and fungi in solutions (Bastiani et al., 1974; Belec et al., 
2000; Jira et al., 1982). BAC at low concentrations is reported to be a non-irritant, non-toxic, and 
non-corrosive to food contact surfaces and thus can be safely used as a disinfectant in the food 
industry as a readily-used antimicrobial agent. However, studies showed that BAC requires 
longer exposure time to inactivate non-enveloped viruses. Furthermore, in our study, longer 
incubation times resulted in higher reduction irrespective of initial titers. Therefore, longer 
contact times could be explored to estimate the effectiveness of BAC in decontaminating HNoV 
surrogates. However, the long contact time of 1 h may not be suitable for all applications.  
Recently, alternatives including trisodium phosphate (TSP) and hydrogen peroxide vapor 
(HPV) are being studied as antiviral sanitizers. TSP at the concentrations of 1%, 2% and 5% 
were tested on surfaces and produce. It appears to be suitable for titer reductions of FCV, MNV-
1 and MS2 bacteriophage on surfaces, and FCV and MNV-1 on produce. Studies showed that 
higher concentration of TSP resulted in higher titer reduction with short contact times (30 s and 1 
min) and 5% TSP achieved similar efficacy to 5000 ppm chlorine (D’Souza and Su, 2010; Su 
and D’Souza, 2011). Though, the adverse effects of high concentrations of alkaline treatments 
such as TSP on the environment, if any, may need to be explored. HPV appears to be a 
promising virucide, showing that poliovirus, rotavirus, adenovirus and murine virus can be 
64 
 
completely inactivated by 127 ppm HPV for 1 h at room temperature on stainless steel and 
framing panel carriers (Tuladhar et al., 2012). Human norovirus GII.4 appeared to be most 
resistant to HPV treatment, with a reduction of 0.5 log10 PCR units on stainless steel carriers. 
Furthermore, their study indicated that low levels of feces (1%) did not significantly influence 
the effectiveness of HPV (Tuladhar et al., 2012). However, the initial cost of the equipment to 
generate HPV may be a limiting factor for some small scale industries or communities.  
Therefore, other commonly used sanitizers and disinfectants need to be evaluated to 
determine their effectiveness against human noroviruses. KPMS is widely used as a powerful 
oxidizing agent. Currently, KPMS is routinely used in swimming pools against Escherichia 
coli to keep the water clean and safe (Anipsitakis et al., 2008). It has also been used as a mist in 
veterinary hospitals to decontaminate S. aureus and S. Typhiumurium by >99.9999% with the 
concentration of 4% for 30 min exposure time after misting was completed (Patterson et al., 
2005). In a 6-year study, KPMS at concentrations of 1 and 10 mg/mL completely inactivated all 
the bacteria-S. aureus, MRSA and Pseudomonas aeruginosa after 10 and 2 min exposure times, 
respectively and no significant variation in resistance to KPMS was observed during the period 
of study (Giacometti et al., 2002). However, only a few studies report the application of KPMS 
for viral inactivation. The KPMS-based product Virkon S was shown to completely inactivate 
the poultry enteric mortality syndrome (PEMS)-associated astrovirus in an embryo model, while 
quaternary ammonium or benzalkonium chloride-based products had no effect against the virus 
(Schultz-Cherry et al., 2001). Also, KPMS was shown to be effective against veterinary isolates 
of FCV (Elarky et al., 2002).  
In our study, KPMS at 5 mg/mL and 10 mg/mL reduced both viruses at low titers within 
30 s and high titers of FCV-F9 after 2 min with 5 mg/mL while within 30 s with 10 mg/mL of 
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KPMS to undetectable levels. High titers of FCV-F9 were reduced to undetectable levels after 2 
min of treatment with 5 mg/mL KPMS. This is consistent with earlier research showing that 
KPMS completely inactivated FCV after 10 min of exposure (Eleraky et al., 2002). However, 
this study used only FCV from animal isolates and not the FCV-F9 strain or MNV-1. KPMS 
appears to be a more suitable disinfectant among the tested chemicals. Though KPMS is fast-
acting, it could be corrosive to surfaces and equipment as a strong oxidative disinfectant, which 
may not be proper for use in hand sanitizers. The applicability of KPMS as an alternative 
strategy to decontaminate foodborne viruses on food contact surfaces (stainless steel) and under 
soiled conditions was investigated in this study as well.  
Solomon and others (2009) reported that 0.8 mg/mL QAC reduced FCV by 1.9 log10 
PFU/mL after 10 min of exposure, while Virkon at 1% containing 5 mg/mL KPMS reduced FCV 
from 4-5 log10 PFU/mL to undetectable levels after 10 min (Solomon et al., 2009). In 
comparison, our results showed that 5 mg/mL KPMS reduced FCV from ~6 log10 PFU/mL to 
undetectable levels after 2 min; and 0.32 mg/mL BAC decreased FCV at ~ 4 log10 PFU/mL by 
1.9 log10 PFU/mL after 1 h. Su and D’Souza (2012) reported that BAC at 0.2, 0.5, and 1 mg/mL 
reduced FCV-F9 and MNV-1 at low (~5 log10 PFU/mL) titers to undetectable levels after 2 h at 
room temperature in suspension tests; and high (~7 log10 PFU/mL) titers of FCV-F9 were 
reduced by 2.87, 3.08, and 3.25 log10 PFU/mL and high titers of MNV-1 were reduced by 1.55, 
2.32, and 2.75 log10 PFU/mL, respectively. KPMS at 5, 10, and 20 mg/mL reduced high and low 
titers of FCV-F9 and low titers of MNV-1 to undetectable levels, while high titers of MNV-1 
were reduced by 0.92 and 3.44 log10 PFU/mL with KMPS at 5 and 10 mg/mL, respectively after 
2 h at room temperature (Su and D’Souza, 2012). In comparison, our study showed that BAC at 
0.32 mg/mL reduced FCV-F9 and MNV-1 at low (~5 log10 PFU/mL) titers by 1.94 and ≥3.14 
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log10 PFU/mL after 1 h at room temperature in suspension tests, respectively; and FCV-F9 and 
MNV-1 at high (~7 log10 PFU/mL) titers were decreased by 2.59 and 1.47 log10 PFU/mL, 
respectively after 1 h. KPMS at 5 and 10 mg/mL reduced both low and high titers of FCV-F9 
and MNV-1 to undetectable levels after 1 h  
Since HNoV is transmitted via fecal-oral route, human excretions such as vomit and 
stools can be the major sources of transmission of HNoV in the environment. Therefore, in 
previous studies, simulated natural conditions have been carried out by adding organic 
compounds into the virus stocks to determine the effect of disinfectants against HNoV and its 
surrogates. In one study, investigators simulated field conditions using an organic acid, an 
aldehyde, a halogen compound, and a peroxide as chemical disinfectants to show that the 
efficacy of disinfectants against FCV and noroviruses could be greatly reduced in the presence of 
organic impurities (25% feces) (Poschetto et al., 2007). However, another study showed that 
organic loads (0.3% BSA plus 0.3% erythrocytes) did not change the effectiveness of the 
biocides (Magulski et al., 2009). In our study, the effect of both chemicals against FCV-F9 and 
MNV-1 decreased under simulated dirty conditions (5% FBS). BAC at 0.32 mg/mL reduced low 
titers of FCV-F9 and MNV-1 by <0.5 log10 PFU/mL under dirty conditions, while undetectable 
levels were achieved under clean conditions after 1 or 2 h exposure time at RT. Moreover, BAC 
resulted in 1.45 and 1.05 log reductions against high titers of FCV-F9 after 1 and 2 h, 
respectively, and ~0.7 log reduction against high titers of MNV-1 after 1 or 2 h under clean 
conditions. However, almost no reduction of FCV-F9 and MNV-1 at high titers after 1 or 2 h 
was observed under dirty conditions. The effect of KPMS at 5 and 10 mg/mL was diminished 
somewhat in the presence of organic loads where 5 mg/mL of KPMS reduced FCV-F9 and 
MNV-1 at low titers to undetectable levels within 30 s and after 2 min under clean and dirty 
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conditions, respectively. KPMS at 10 mg/mL showed no difference against FCV-F9 at both high 
and low titers and MNV-1 at low titer under clean or dirty conditions; however, effects 
significantly decreased against high titers of MNV-1, resulting in complete inactivation after 15 
min and 1 h under clean and dirty conditions, respectively.  
Conclusion 
This study provides data on alternative methods for HNoV surrogate reduction. Further 
studies using higher concentrations of BAC may be necessary to determine the efficacy of its 
antiviral effects against HNoV surrogates for use in food processing, hospital or industrial 
settings. Our results with KPMS show its strong potential for application in decontaminating 
enteric viruses in a rapid and effective manner, though caution is advised as it is a strong 
oxidizing agent.  
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Table 2.1: Reduction of low and high titers of FCV-F9 and MNV-1 at room temperature by 0.32 mg/mL benzalkonium chloride (BAC) 
using suspension tests.  
 
FCV-F9 (log10 PFU/mL) at Low 
titer 
MNV-1 (log10 PFU/mL) at Low 
titer 
FCV-F9 (log10 PFU/mL) at High 
titer 




Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Control 4.66±0.13A 0.00 4.41±0.17A 0.00 6.42±0.14A 0.00 6.24±0.06A 0.00 
5 4.10±0.17B 0.56 4.09±0.25AB 0.32 5.76±0.09B 0.66 5.40±0.31AB 0.84 
10 4.04±0.06B 0.62 3.84±0.21BC 0.57 5.39±0.08C 1.03 5.33±0.32AB 0.91 
15 3.85±0.15BC 0.81 3.68±0.24CD 0.73 5.16±0.09C 1.26 5.01±0.36B 1.23 
30 3.55±0.09C 1.11 3.35±0.12D 1.06 4.43±0.10D 1.99 4.93±0.46B 1.31 
60 2.73±0.25D 1.94 <10E ≥3.41* 3.83±0.09E 2.59 4.77±0.39B 1.47 
 
Different letters denote significant differences when compared within each column alone (p<0.05).  
*Indicates inactivation values at the detection limit of the assay since BAC fixed the cell monolayers after 1 log serial dilution but not 








Table 2.2: Reduction of FCV-F9 and MNV-1 at high titers by potassium peroxymonosulfate (KPMS) at 5 and 10 mg/mL at room 
temperature in suspension tests.  
 
 
FCV-F9 (log10 PFU/mL) with 5 
mg/mL KPMS 
MNV-1 (log10 PFU/mL) with 5 
mg/mL KPMS 
FCV-F9 (log10 PFU/mL with 10 
mg/mL KPMS 





Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Control 6.41±0.15A 0.00 6.45±0.12A 0.00 6.00±0.08A 0.00 6.16±0.07A 0.00 
0.5 3.71±0.06B 2.70 6.04±0.10B 0.41 <10B ≥5.00* 3.98±0.10B 2.18 
1 2.10±0.19C 4.31 5.87±0.20B 0.58 <10B ≥5.00* 2.91±0.15C 3.25 
2 <10D ≥5.41* 5.98±0.05B 0.47 <10B ≥5.00* 2.48±0.16D 3.68 
5 <10D ≥5.41* 5.97±0.09B 0.48 <10B ≥5.00* 1.55±0.23E 4.61 
 
Different letters denote significant differences when compared within each column alone (p<0.05).  
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution 




Table 2.3: Reduction of FCV-F9 and MNV-1 at high titers on clean (a) and dirty (b) sterile stainless-steel coupons (carrier tests) by 5 
mg/mL and 10 mg/mL potassium peroxymonosulfate (KPMS) at room temperature.  
a.  
 
FCV-F9 (log10 PFU/mL) with 5 
mg/mL KPMS 
MNV-1 (log10 PFU/mL) with 5 
mg/mL KPMS 
FCV-F9 (log10 PFU/mL) with 10 
mg/mL KPMS 




Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Control 7.51±0.08A 0.00 5.83±0.07A          0.00 7.51±0.08A 0.00 5.83±0.07A 0.00 
0.5 7.25±0.06AB 0.26 5.79±0.03A 0.04 6.36±0.07B 1.15 5.02±0.18B 0.81 
1 6.95±0.09B 0.56 5.69±0.07AB 0.14 6.40±0.05B 1.11 5.12±0.04B 0.71 
2 6.86±0.11B 0.65 5.58±0.13B 0.25 5.70±0.18B 1.81 4.44±0.08B 1.39 
5 7.03±0.14B 0.48 5.16±0.09C 0.67 5.59±0.40B 1.92 4.27±0.23B 1.56 
10 <10C ≥6.51* 4.19±0.06B 1.64 <10C ≥6.51* 3.11±0.06B 2.72 
15 <10C ≥6.51* 4.18±0.10B 1.65 <10C ≥6.51* <10C ≥4.83* 
30 <10C ≥6.51* 3.63±0.12C 2.20 <10C ≥6.51* <10C ≥4.83* 
60 <10C ≥6.51* 3.37±0.21C 2.46 <10C ≥6.51* <10C ≥4.83* 
 
Different letters denote significant differences when compared within each column alone (p<0.05).  
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution 




Table 2.3: Reduction of FCV-F9 and MNV-1 at high titers on clean (a) and dirty (b) sterile stainless-steel coupons (carrier tests) by 5 
mg/mL and 10 mg/mL potassium peroxymonosulfate (KPMS) at room temperature (Continued).  
b.  
 
FCV-F9 (log10 PFU/mL) with 5 
mg/mL KPMS 
MNV-1 (log10 PFU/mL) with 5 
mg/mL KPMS 
FCV-F9 (log10 PFU/mL) with 10 
mg/mL KPMS 




Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Control 7.98±0.03A 0.00 5.85±0.09A          0.00 7.98±0.03A 0.00 5. 85±0.09A 0.00 
10 2.71±0.08B 5.27 4.59±0.03B 1.26 <10B ≥6.98* 3.51±0.09B 2.34 
15 <10C ≥6.98* 4.43±0.09BC 1.42 <10B ≥6.98* 3.33±0.06B 2.52 
30 <10C ≥6.98* 4.26±0.02C 1.59 <10B ≥6.98* 2.83±0.13C 3.02 
60 <10C ≥6.98* 3.56±0.13D 2.29 <10B ≥6.98* <10C ≥4.85* 
 
Different letters denote significant differences when compared within each column alone (p<0.05).  
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution 







Table 2.4: Reduction of FCV-F9 and MNV-1 at high titers on clean sterile stainless-steel coupons 
by 0.32 mg/mL BAC at room temperature.  
 
FCV-F9 (log10 PFU/mL) MNV-1 (log10 PFU/mL) 
Contact time 
 
Recovered titer Reduction Recovered titer Reduction 
Water 1 h 7.88±0.05A 0.00 5.60±0.12A 0.00 
1 h 6.43±0.08B 1.45 4.84±0.11BC 0.76 
Water 2 h 6.78±0.32B 0.00 5.41±0.33AB 0.00 
2 h 5.73±0.05C 1.05 4.71±0.24C 0.70 
 





















Table 2.5: Reduction of FCV-F9 and MNV-1 at high and low titers on sterile stainless-steel coupons with 5% FBS (dirty condition) by 
0.32 mg/mL BAC at room temperature.  
 
 
FCV-F9 (log10 PFU/mL) at Low 
titer 
MNV-1 (log10 PFU/mL) at Low 
titer 
FCV-F9 (log10 PFU/mL) at High 
titer 




Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Water 1 h 6.03±0.02A 0.00 4.38±0.07A 0.00 8.14±0.06A 0.00 5.90±0.08A 0.00 
1 h 5.85±0.18AB 0.18 4.17±0.06B 0.21 8.14±0.03A 0.00 5.01±0.04C 0.89 
Water 2 h 6.10±0.03A 0.00 4.40±0.08A 0.00 8.19±0.05A 0.00 5.99±0.06A 0.00 
2 h 5.56±0.11B 0.54 3.94±0.08C 0.46 8.01±0.02B 0.18 5.62±0.02B 0.36 
 




Table 2.6: Reduction of FCV-F9 and MNV-1 at low titers on dirty carrier tests by 5 and 10 mg/mL potassium peroxymonosulfate 
(KPMS) at room temperature.  
 
 
FCV-F9 (log10 PFU/mL) with 5 
mg/mL KPMS 
MNV-1 (log10 PFU/mL) with 5 
mg/mL KPMS 
FCV-F9 (log10 PFU/mL) with 10 
mg/mL KPMS 




Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction Recovered titer Reduction 
Control 6.03±0.07A 0.00 3.67±0.09A          0.00 5.93±0.09A 0.00 3.67±0.09A 0.00 
0.5 4.09±0.06B 1.94 1.76±0.31B 1.91 2.43±0.09B 3.50 <10B ≥2.67* 
1 3.72±0.04C 2.31 1.46±0.22B 2.21 <10C ≥4.93* <10B ≥2.67* 
2  <10C ≥5.03* <10C ≥2.67* <10C ≥4.93* <10B ≥2.67* 
 
Different letters denote significant differences when compared within each column alone (p<0.05).  
*Indicates inactivation values at the detection limit of the assay since KPMS fixed the cell monolayers after the first-log serial dilution 
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Sodium metasilicate is USDA FSIS approved as a processing aid for meat and poultry 
products with known antibacterial properties and anti-rotaviral activity. However, its efficacy 
against human noroviruses, the leading cause of non-bacterial gastroenteritis, has not been 
reported. Concentration-dependent effects of sodium metasilicate at 2%, 5%, and 10% against 
cultivable human norovirus surrogates, (feline calicivirus (FCV-F9) and murine norovirus 
(MNV-1)), at room temperature for up to 1 h using both suspension and carrier tests were 
evaluated. Each virus at high (6~8 log10 PFU/mL) or low (4~6 log10 PFU/mL) titers was mixed 
with equal volumes of sodium metasilicate and incubated for 15 s, 30 s, 1 min, 2 min, 5 min, 10 
min, 15 min, 30 min and 1 h. Each treatment was replicated thrice, recovered viruses were 
plaque assayed in duplicate, and data was statistically analyzed. Virus reduction by 5 and 10% 
sodium metasilicate was rapid, with complete reduction within 15 s for both tested viruses at 
both titers using suspension tests.  FCV-F9 and MNV-1 at high titers were reduced to 
undetectable levels with 2% sodium metasilicate after 2 min and 15 s, respectively; with 
complete reduction of  both viruses at low titers within 15 s. For carrier tests, under dry 
conditions, complete reduction of FCV-F9 at high titers was achieved by 2 and 5% sodium 
metaslicate after 10 min and 15 s, respectively; high titers of MNV-1 were reduced to 
undetectable levels by 2% sodium metasilicate after 2 min; and complete reduction of both tested 
viruses at low titers were observed within 15 s.  This research shows the potential application of 






Human noroviruses are non-enveloped, single-stranded RNA viruses that belong to the 
Caliciviridae family. They are currently considered the leading cause of foodborne illness 
outbreaks worldwide. In the United States, over half of the foodborne disease outbreaks reported 
by the Centers for Disease Control and Prevention from 2006 to 2008 were attributed to human 
noroviruses (Scallen et al., 2011; Siebenga et al., 2009; CDC, 2011). The difficulty involved in 
controlling human norovirus outbreaks are due to their ease of transmission, high attack rates, 
environmental stability and low infectious doses of 10 to 100 viral particles (Caul, 1994; 
D'Souza et al., 2006; Liu et al., 2009). The virus can be transmitted by person to person, or via 
the fecal-oral route (Goodgame et al., 2006). In addition, people may be infected by consuming 
contaminated food or water and touching inanimate objects contaminated with the virus. 
Outbreaks have occurred in a variety of closed settings, including long-term care and other 
healthcare facilities, restaurants and catered events, cruise ships, schools, hotels, and other 
institutional settings and also involve ready-to-eat food items that do  not undergo further 
processing before consumption (CDC, 2011). The symptoms include nausea, vomiting, diarrhea 
and abdominal pain. Although the infection is self-limiting, the emerging virulent strains can be 
life-threatening to the elderly and the immuno-compromised (Siebenga et al., 2009; Donaldson et 
al., 2010).  Routine sanitation and hygienic practices need to be followed to prevent outbreaks. 
Commonly used sanitizers including chlorine containing compounds have been found to be 
efficacious for surface decontamination (D’Souza and Su, 2010).  
Sodium metasilicate is a commonly used USDA FSIS approved processing aid in the 
food industry that is highly soluble with the pH of a 1% solution ranging from 12.5 to 13.0 
(Sharma et al., 2012a). It is approved for use as an antimicrobial component of marinades for 
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meat and poultry products at up to 2% by weight of the marinades and also as a carcass rinse or 
spray on raw beef carcasses, subprimals, and trimmings at up to 6% in solutions (USDA FSIS, 
2011). Sodium metasilicate has been shown to be effective against foodborne bacterial pathogens 
including Escherichia coli O157: H7 and Salmonella species both in vitro and in beef trimmings 
(Carlson et al., 2008; Geornaras et al., 2012; Pohlman et al., 2007; Weber et al., 2004), and also 
Campylobacter jejuni and Salmonella Typhimurium in fresh chicken breast meat (Sharma et al., 
2012a, b). Weber et al. (2004) found that sodium metasilicate at 0.6% (pH 12.1) resulted in 
complete inhibition of E. coli O157: H7 after a 5 to 10 s exposure in water at room temperature 
(Weber et al., 2004). Carlson et al., (2008) reported that 4% sodium metasilicate (23oC, pH 
12.94) reduced E. coli O157: H7 and Salmonella by ~1.9 and ~ 2.6 log CFU/mL, respectively 
from inoculated beef hides following a 30 s- spray- 2 min- dwell- 30 s - water rinse procedure 
(Carlson et al., 2008). Pohlman et al. (2009) demonstrated that E. coli and Salmonella 
Typhimurium were reduced by ~1 log to ≥1.5 log CFU/mL, respectively, after treatment with 
4% sodium metasilicate on inoculated beef trimmings (Pohlman et al., 2009). Geornaras et al. 
(2012) found similar effectiveness of sodium metasilicate against E.coli O157:H7 and 6 non-
O157 Shiga toxin-producing E. coli (nSTEC) serogroups. After immersion for 30 s in a solution 
of 4% sodium metasilicate (pH 12.5), initial pathogen counts were found to be reduced by 1.3 to 
1.5 log CFU/cm2 on inoculated beef trimmings from an initial count of 3 to 4 log CFU/cm2 
(Geornaras et al., 2012). Adler et al. (2011) observed that brine solution containing 2.2% sodium 
metasilicate immediately reduced E.coli O157:H7 by ≥2.4 log CFU/mL at 4 or 15 oC(Adler et 
al., 2011).  
Besides these foodborne bacterial pathogens, sodium metasilicate has also been evaluated 
for its efficacy against viral pathogens, including human rotaviruses and vesicular stomatitis 
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viruses (Springthorpe et al., 1986; Wright 1970). Springthorpe et al. (1986) tested the efficacy of 
69 commercial and 7 non-commercial disinfectant formulations against human rotaviruses and 
found that the efficacy of quaternary ammonium-based disinfectant formulations was greatly 
improved by adding 0.5 to 5% sodium metasilicate, being effective against human rotaviruses. 
They believed that quaternary ammonium compounds and sodium metasilicate may act in an 
additive or synergistic manner to inactivate human rotaviruses (Springthorpe et al., 1986). 
However, information is currently lacking on the antiviral activity of sodium metasilicate against 
human norovirus surrogates in vitro. The objective of this study was to determine the ability of 
2%, 5%, and 10% sodium metasilicate to inactivate human norovirus surrogates, FCV-F9 and 
MNV-1, in suspension and using carrier tests (stainless steel coupons) at room temperature.  
 
Materials and Methods 
Virus stocks and cell lines: Feline calicivirus (FCV-F9) and its host, Crandell Reese 
Feline Kidney (CRFK) cells, were obtained from American type culture collection (ATCC) 
(Manassas, VA). Murine norovirus (MNV-1) was kindly provided by Dr. Skip Virgin 
(Washington University, St. Louis, MO), and its host, RAW 264.7 cells were obtained from the 
University of Tennessee cell culture collection. Viral stocks containing ~6 log10 PFU/mL of 
MNV-1 and ~8 log10 PFU/mL of FCV-F9 were obtained as previously described using their 
respectively confluent cell lines in 175cm2 flasks (D’Souza et al., 2011; Su et al., 2011).  
Chemicals: Sodium metasilicate obtained from MP Biomedicals (Solon, OH, USA) was 
dissolved in de-ionized water and then filtered through 0.2μm filters (Fisher Scientific, GA, 
USA) to reach concentrations of 10% (w/v), 5% (w/v), and 2% (w/v).  
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Treatments: For suspension tests, one volume (167μl) of sodium metasilicate was 
mixed with the same volume of virus to reach final concentrations of 5% (w/v), 2.5% (w/v), and 
1% (w/v) and incubated for 15 s, 30 s, 1 min, 2 min, 5 min, 10 min, 15 min, 30 min and 1 h at 
room temperature. Sterile de-ionized water was used as a control to compare with the treated 
samples. At each time point, treatments were neutralized by serially diluting in Dulbecco’s 
Modified Eagle’s Medium/Ham’s F-12 (DMEM, HyClone Laboratories, Inc, Logan, Utah) 
containing 10% heat-inactivated Fetal Bovine Serum (FBS, HyClone Laboratories, Inc, Logan, 
Utah), followed by serial dilutions in DMEM containing 2% heat-inactivated FBS.  
For the carrier test, stainless steel coupons sterilized by autoclaving were used as a 
surface model (fomite) to simulate natural conditions. MNV-1 and FCV-F9 were inoculated on 
sterile coupons at high and low titers and allowed to dry for 1 h at room temperature in a 
BioSafety Level 2 hood. After drying, the coupons were treated with 2% sodium metasilicate for 
various time intervals from 0, 15 s, 30 s, 1, 2, 5, 10, 15, 30 and 60 min at room temperature (RT). 
Plaque Assays: Treated samples and controls were inoculated onto the confluent CRFK 
cells for FCV-F9 and RAW 267.4 cells for MNV-1 in 6-well plates, and incubated for 2.5 h at 37
℃ under 5% CO2. Then overlay media containing 0.75% (w/v) noble agar was added to each 
well and incubated for 2 to 3 days at 37℃ in a CO2 incubator. Finally, neutral red (Sigma-
Aldrich, St. Louis, MO) containing overlay media was added and incubated for 3 to 24 h  to 
visualize the plaques.  
Statistical Analysis: All treatments and controls were replicated three times in 
duplicates. A one-way analysis of variance (ANOVA) was used to test for differences in means 
of plaque counts among treatments and means were analyzed using a completely randomized 
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design at p<0.05 in SAS program (version 9.3, SAS Institute, Cary, NC, USA).  If statistically 
significant differences were found using the ANOVA, the Tukey’s Post Hoc test was used to 
analyze differences in means between treatments.  
Results 
Effect of 5 and 10% sodium metasilicate against FCV-F9 and MNV-1 at high and 
low titers in suspension tests: Both 5 and 10% sodium metasilicate reduced high and low titers 
of FCV-F9 and MNV-1 to undetectable levels within 15 s at room temperature (data not shown).  
Effect of 2% sodium metasilicate against FCV-F9 and MNV-1 in suspension tests: 
Sodium metaslicate at 2% reduced FCV-F9 at low titers and MNV-1 at both high and low titers 
to undetectable levels within 15 s at room temperature. The reduction caused by 2% sodium 
metasilicate on high titers of FCV-F9 in suspension tests are shown in Table 3.1. FCV-F9 at high 
titers were reduced by 5.42, 6.02, and 6.18 log PFU by 2% sodium metasilicate after 15 s, 30 s, 
and 1 min, respectively; and complete reduction was observed after 2 min contact time at room 
temperature.  
Effect of 2% sodium metasilicate against FCV-F9 and MNV-1 in carrier tests: Low 
titers of FCV-F9 and MNV-1 were reduced to undetectable levels within 15 s at room 
temperature using stainless steel coupons. The effects of 2% sodium metasilicate on high titers of 
FCV-F9 and MNV-1 in carrier tests are shown in Table 3.2. Compared to the titer reduction of 
the tested viruses at high titers in suspension tests, the titer reduction of FCV-F9 and MNV-1 in 
carrier tests appeared to be slightly lower, where 2% sodium metasilicate decreased the FCV-F9 
at high titers by 2.28, 3.19, 3.59 and 4.80 log10 PFU/mL, respectively after 30 s, 1 min, 2 min and 
5 min of exposure time. High titers of MNV-1 were decreased by 1.04 and 2.02 log10 PFU/mL 
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after 30 s and 1min, respectively with 2% sodium metasilicate. FCV-F9 and MNV-1 were 
reduced to non-detectable limits (based on the detection limit of the plaque assays 1 log10 
PFU/mL) by 2% sodium metasilicate after 10 min and 2 min of contact times at room 
temperature, respectively.  
Discussion 
In the present study, the effect of sodium metasilicate at concentrations of 2%, 5%, and 
10% on inactivation of FCV-F9 and MNV-1 was evaluated. Sodium metasilicate was found to 
cause rapid reduction in titers of the tested human noroviral surrogates. FCV-F9 and MNV-1 at 
low titers were reduced to undetectable levels within 15 s by 2% sodium metasilicate in both 
suspension and carrier tests at room temperature. Complete reduction of FCV-F9 and MNV-1 at 
high titers was achieved by 2% sodium metasilicate after 2 min and within 15 s in suspension 
tests, respectively. In carrier tests, high titer FCV-F9 and MNV-1 were reduced to undetectable 
levels after 10 min and 2 min at room temperature, respectively. Increasing the concentrations of 
sodium metasilicate to 5 and 10% were found to reduce FCV-9 and MNV-1 at high titers to 
undetectable levels within 15 s in both suspension and carrier tests. The results revealed the 
potential suitability of using sodium metasilicate to prevent the transmission of human noroviral 
outbreaks. 
Chemicals other than sodium metasilicate used include trisodium phosphate (TSP), a 
common household cleanser, which is also an alkaline detergent with the pH of 12 in 1% 
solution, and considered as GRAS by the FDA (Lindsay 1985). TSP is reported to be effective 
against a wide range of pathogens, including E. coli O157: H7, Salmonella, Poliovius 1 and 
bacteriophages. Jerzy and others (2003) reported that significant reductions of bacteriophage 
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MS2 and poliovirus1 were obtained using 1.0% TSP solution on strawberries (Jerzy et al., 2003). 
D’Souza and Su (2010) reported that 5% TSP effectively inactivated high titers of MNV-1 and 
FCV-F9 by ≥6 log PFU/mL, and with ~ 5 log reduction of low viral titers after 30s or 1 min 
contact time. TSP at 2% were found to  inactivate high titers of FCV-F9 by ≥6 log PFU/mL, but 
only a 1.05 log reduction for MNV-1 after 1 min was obtained. TSP at 1% was also reported to 
reduce FCV-F9 by ~2.65 log PFU/mL, while no reduction was observed for high titers of MNV-
1 (D'Souza and Su, 2010). In this study, sodium metasilicate at the lower concentrations of 2% 
appears to be more effective than TSP for the titer reduction of these human noroviral surrogates.  
The mechanism of antibacterial activity of TSP is believed to be due to a combination of 
high pH (~12), ionic strength and detergent effects that can cause cell wall and membrane 
disruption of Gram-negative foodborne pathogens (Mendonca et al., 1994; Sampathkumar et al., 
2003; Yuk and Marshall, 2006). However, the mechanism of virucidal activity has not been 
elucidated. The mechanism of antimicrobial effect of sodium metasilicate could be similar to 
TSP in that they are both strongly alkaline. Further research is needed to explore the antiviral 
mechanism of action.   
The application of sodium metasilicate in food industry can be broader than TSP, as 
sodium metasilicate has been approved to be directly added in food as a processing aid to wash 
fruits, vegetables, and nuts. It can also be applied in poultry and meat products as an 
antimicrobial (US FDA 2003). Furthermore, previous studies have shown that sodium 
metasilicate can maintain the quality of fresh commercial poultry, having no negative effects on 
sensory, physical or chemical characteristics. These investigators found that 1-4% sodium 
metasilicate did not adversely affect sensory characteristics, color, texture or pH of fresh 
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commercial chicken breast meat at 4oC after 9 days (Huang et al., 2011). Pohlman et al.,  (2009) 
also reported little impact of sensory odor and color characteristics was observed by 4% sodium 
metasilicate in beef trimmings (Pohlman et al., 2009). Additionally, Quilo et al. (2010) revealed 
that better quality were perceived by using 4% sodium metasilicate in beef trimmings, resulting 
in much juicier, lower Warner-Bratzler shear force value for texture, and less cooking loss than 
the control samples (Quilo et al., 2010).  
Besides alkaline chemical treatments, acidic solutions, including lactic acid and 
peroxyacetic acid, also have a long history of commercial use for the inactivation of foodborne 
pathogens. The mode of action of these organic acids and its salts on foodborne bacteria 
pathogens appears to be the result of the diffusion of the undissociated form of the acid into the 
cell, leading to decreasing intracellular pH. In order to sustain the pH inside the cell, ATPase 
pumps out protons at the expense of ATP. Eventually, cells die due to the lack of cellular energy 
(Bogaert and Naidu, 2000). The acid mediated mechanisms leading to a loss of infectivity of 
foodborne viruses has not been completely understood, which is believed to result from the 
alterations of the virus capsid and nucleic acid (Cliver, 2009; Salo and Cliver, 1976). However, 
whether the effect was derived from the decrease in pH or the type of acid is still not clear. It is 
appeared that the inactivation of non-enveloped viruses is due to the denaturation of the capsid 
proteins due to the decrease in pH (Rodger et al., 1977).  
Previous research has shown the effect of lactic acid and peroxyacetic acid against human 
norovirus surrogates. Using suspension tests, Straube et al., (2011) found that D, L-lactic acid at 
the concentration of 0.3% (pH 3.4-3.5) and 0.4% (pH 3.2-3.3) could reach a significant titer 
reduction of FCV-F9 after 7 days at 20°C (Straube et al., 2011). Baert et al., (2009) reported that 
the application of 250 mg/L peroxyacetic acid to washing solution could obtain a supplementary 
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1-log reduction of MNV-1 on shredded iceberg lettuce (compared to tap water), and its efficacy 
was not influenced by the presence of organic materials (Baert et al., 2009). Fraisse et al., (2011) 
found that 100 ppm of peroxyacetic-based biocide effectively inactivated FCV-F9 by 3.2 log 
units and MNV-1 by 2.3 log units on the lettuce leaves after 2 min of contact time, as estimated 
by cell culture (Fraisse et al., 2011).  
Other effective cleansers, including chlorine have been commonly used to disinfect 
foodborne pathogens. Chlorine has been tested for antiviral activity against human norovirus 
surrogates and found to be very effective in inactivating FCV-F9 and MNV-1 in suspension, on 
surfaces, and on produce (Belliot et al., 2008; D'Souza and Su, 2010; Doultree et al., 1999; 
Duizer et al., 2004; Fraisse et al., 2011; Kitajima et al., 2010; Urakami et al., 2007). However, 
due to the corrosive nature of chlorine, bleaching of food and unfavorable sensory effects, it has 
limitations for use. Furthermore, by-products including trihalomethanes may be generated due to 
interaction with organic matters, which can cause carcinogenic products and potential risks to 
public health (Dunnick and Melnick, 1993). Overall, based on the findings of this study, sodium 
metasilicate may be suitable and applicable for the food industry to decrease foodborne human 
noroviral transmission risk. 
Conclusion 
Sodium metasilicate at 2% is found to be very suitable for inactivating human norovirus 
surrogates, FCV-F9 and MNV-1 in both suspension and carrier tests, indicating its potential use 
as an antiviral component for surface disinfection or could be potentially used in marinades. This 
chemical is already approved as a processing aid in meat and poultry products and being fast-
acting has great promise to reduce human norovirus surrogate transmision. The application of 
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sodium metasilicate as an alternative coating or strategy to decontaminate foodborne viruses in 
foods, such as meat and fresh produce, needs to be investigated.  
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Table 3.1: The effect of sodium metasilicate at 2% on reduction of FCV-F9 at high titer using 
suspension tests at room temperature.  
 
FCV-F9 (log10 PFU/mL) 
Contact time 
 
Recovered titer Reduction 
Control  7.86±0.08A 0.00 
15 s 2.45±0.16B 5.41 
30 s 1.84±0.34BC 6.02 
1 min 1.68±0.23C 6.18 
2 min <10D ≥6.86* 
5 min <10D ≥6.86* 
 
Different letters denote significant differences when compared within each column alone 
(p<0.05).  
*Indicates inactivation values at the detection limit of the assay since sodium metasilicate fixed 
the cell monolayers after the first-log serial dilution but not the lower dilutions of the virus-




Table 3.2: The effect of sodium metasilicate at 2% on reduction of FCV-F9 and MNV-1 at high 
titers using carrier tests at room temperature.  
 
FCV-F9 (log10 PFU/mL) MNV-1 (log10 PFU/mL) 
Contact time 
 
Recovered titer Reduction Recovered titer Reduction 
Control  7.97±0.08A 0.00 5.74±0.11A 0.00 
30 s 5.69±0.17B 2.28 4.70±0.04B 1.04 
1 min 4.79±0.12C 3.18 3.72±0.06C 2.02 
2 min 4.38±0.16D 3.59 <10D ≥4.74* 
5 min 3.17±0.15E 4.80 <10D ≥4.74* 
10 min <10F ≥6.97* <10D ≥4.74* 
15 min <10F ≥6.97* <10D ≥4.74* 
 
Different letters denote significant differences when compared within each column alone 
(p<0.05).  
*Indicates inactivation values at the detection limit of the assay since sodium metasilicate fixed 
the cell monolayers after the first-log serial dilution but not the lower dilutions of the virus-
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